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ABSTRACT Actin retrograde flow and actomyosin II contraction have both been implicated 
in the inward movement of T cell receptor (TCR) microclusters and immunological synapse 
formation, but no study has integrated and quantified their relative contributions. Using Jur-
kat T cells expressing fluorescent myosin IIA heavy chain and F-tractin—a novel reporter for 
F-actin—we now provide direct evidence that the distal supramolecular activation cluster 
(dSMAC) and peripheral supramolecular activation cluster (pSMAC) correspond to lamellipo-
dial (LP) and lamellar (LM) actin networks, respectively, as hypothesized previously. Our im-
ages reveal concentric and contracting actomyosin II arcs/rings at the LM/pSMAC. Moreover, 
the speeds of centripetally moving TCR microclusters correspond very closely to the rates of 
actin retrograde flow in the LP/dSMAC and actomyosin II arc contraction in the LM/pSMAC. 
Using cytochalasin D and jasplakinolide to selectively inhibit actin retrograde flow in the LP/
dSMAC and blebbistatin to selectively inhibit actomyosin II arc contraction in the LM/pSMAC, 
we demonstrate that both forces are required for centripetal TCR microcluster transport. Fi-
nally, we show that leukocyte function–associated antigen 1 clusters accumulate over time at 
the inner aspect of the LM/pSMAC and that this accumulation depends on actomyosin II con-
traction. Thus actin retrograde flow and actomyosin II arc contraction coordinately drive re-
ceptor cluster dynamics at the immunological synapse.
INTRODUCTION
The activation of T lymphocytes involves antigen receptors, adhe-
sion molecules, and other accessory components, all of which polar-
ize rapidly toward the site of contact with the antigen-presenting 
cell (APC; Fooksman et al., 2010). On binding their respective li-
gands on the surface of the APC, these proteins undergo differential 
clustering and rearrangement at the synaptic junction to form two 
segregated, concentric domains known as supramolecular activat-
ing clusters (SMACs; Monks et al., 1998; Grakoui et al., 1999). The 
resulting bull’s-eye pattern of SMACs is a hallmark of the immuno-
logical synapse (IS) and provides the structural basis for signaling 
and secretion at the T cell–APC interface. The center area of the IS, 
known as the central SMAC (cSMAC), is marked by the accumula-
tion of T cell receptor (TCR) microclusters (MCs), which are bound to 
major histocompatibility complex (MHC) proteins displaying anti-
genic peptide present on the surface of the APC (Campi et al., 2005; 
Yokosuka et al., 2005). The surrounding ring of the bull’s eye, known 
as the peripheral SMAC (pSMAC), is marked by clusters of the β2-
integrin leukocyte function–associated antigen 1 (LFA-1), which are 
bound to intercellular adhesion molecule 1 (ICAM-1) present on the 
APC surface (Monks et al., 1998; Grakoui et al., 1999). Recent stud-
ies argue that TCR signaling is degraded at the cSMAC and that 
active signaling actually takes place at the periphery of the IS (Varma 
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parison, therefore, is that the centripetal movement of receptor 
clusters may well be driven by a combination of the pushing force 
provided by polymerization-based actin retrograde actin flow in the 
LP and the pulling force provided by myosin II–based contraction of 
transverse actin bundles in the LM (Medeiros et al., 2006; Gardel 
et al., 2010; Wilson et al., 2010).
With regard to the possible role of myosin II in the centripetal 
transport of TCR MCs, an early study using blebbistatin (BB) to in-
hibit myosin II argued that the myosin is not required for IS forma-
tion (Jacobelli et al., 2004). In contrast, a subsequent study using 
both BB and RNA interference (RNAi) knockdown of myosin IIA re-
ported a dramatic inhibition of inward TCR MC movement, SMAC 
formation, and IS stability (Ilani et al., 2009). Although convincing in 
many aspects, this study did not image the dynamics of F-actin or 
myosin II, determine the effect of myosin II inhibition on the rate of 
actin flow, define the organization of F-actin within the LM/pSMAC, 
or pinpoint the site of action of myosin II within the IS. Moreover, it 
did not parse out the relative contributions made by actin retro-
grade flow and myosin II–based contraction to the centripetal trans-
port of TCR MCs. Armed with a novel reporter for F-actin, we sought 
here to address these and related unresolved questions regarding 
the role of the actin cytoskeleton in IS formation.
RESULTS
The region of the IS corresponding to the LM/pSMAC 
contains concentric actin arcs that are rich in myosin IIA
To examine in greater detail the organization of cortical F-actin at 
the IS, we used E6.1 Jurkat T cells stimulated by glass-supported 
planar lipid bilayers containing anti-CD3ε antibody and ICAM-1 
(Kaizuka et al., 2007; see Materials and Methods). Anti-CD3ε anti-
body labeled with rhodamine-X and attached to biotinylated lipids 
in the bilayer via a streptavidin bridge distributes evenly in bilayers 
(data not shown). Moreover, use of fluorescence recovery after 
photobleaching (FRAP) to assess the lateral mobility of ICAM-1 
tagged with Alexa 647 and attached to the bilayer via nitrilotria-
cetic acid (NTA)–conjugated lipids indicated that the lipids in these 
bilayers are diffusing freely and uniformly (Supplemental Figure 
S1, A1–A3). Finally, after 5 min of engagement with the bilayer, the 
vast majority (93.8%, n = 32 cells; Supplemental Figure S1B) of 
Jurkat T cells formed the central accumulation of TCR MCs, as in-
ferred from the distribution of the anti-CD3ε antibody in the bi-
layer, and the peripheral accumulation of the integrin LFA-1, as 
inferred from the distribution of ICAM-1 in the bilayer, which is 
characteristic of the bull’s-eye–patterned IS formed by primary T 
cells bound to bilayers containing peptide-MHC (Grakoui et al., 
1999).
To image the endogenous network of cortical F-actin at the plane 
of the IS, Jurkat T cells were stained with rhodamine–phalloidin 
(Figure 1, A1–A4; two representative cells are shown; unless indi-
cated otherwise, all fixations were performed 5 min after engage-
ment with the bilayer). This staining revealed three visually distinct 
rings or zones of F-actin at the IS: an outer ring characterized by very 
intense F-actin staining interrupted by streaks, a middle ring charac-
terized by concentric arcs of F-actin, and a central zone relatively 
free of F-actin (Figure 1, A1 and A3, and the corresponding insets in 
A2 and A4, respectively: the cell in A1 shows the outer ring most 
clearly, and the cell in A3 shows the middle ring best). Of impor-
tance, the middle ring containing the concentric F-actin arcs over-
laps extensively with the high concentration of ICAM-1 clusters that 
indirectly mark the position of the pSMAC (Figure 1, B1, B3, and B5, 
and the corresponding insets in B2, B4, and B6). Moreover, the 
central zone that is essentially devoid of F-actin overlaps almost 
serve dual functions during T cell activation: as a zone of adhesion 
between the T cell and the APC, and as a zone of active TCR signal-
ing at the IS. Substitution of the APC surface with a glass-supported 
planar lipid bilayer displaying stimulatory molecules has been shown 
to replicate the signaling activity and spatial organization of the IS 
and has become an important tool for studying T cell activation 
(Grakoui et al., 1999; Dustin, 2009).
The creation of the bull’s-eye pattern exhibited by the mature IS 
requires the centripetal transport of both TCR MCs and integrin 
clusters, as well as their differential sorting at the pSMAC/cSMAC 
boundary. The vast majority of previous studies (see the Discussion 
for one recent exception) point to the inward flow of cortical F-actin 
at the IS as the major if not sole driving force behind centripetal re-
ceptor cluster movement (Billadeau et al., 2007; Kaizuka et al., 2007; 
DeMond et al., 2008; Hartman et al., 2009; Yu et al., 2010). First, 
dynamic imaging of F-actin at the IS using green fluorescent protein 
(GFP)–actin as the reporter reveals very robust actin polymerization–
driven retrograde actin flow at the perimeter of the IS (Bunnell et al., 
2001; Kaizuka et al., 2007; Yu et al., 2010). Moreover, this flow is ra-
dially symmetric, fully consistent with a symmetric centering force. 
Second, the inward movement of TCR MCs does not begin until 
leading-edge actin polymerization converts from initial cell spread-
ing to retrograde flow upon completion of spreading (DeMond 
et al., 2008). Third, the centripetal movement of preformed TCR 
MCs completely ceases upon depolymerization of F-actin by latrun-
culin (Varma et al., 2006; Kaizuka et al., 2007).
Consistent with centripetal actin flow driving receptor cluster 
movement, simultaneous imaging of TCR MCs, integrin clusters, 
and F-actin (using GFP-actin) at the periphery of bilayer-engaged 
Jurkat T cells showed that both types of clusters move inward with 
actin flow (Kaizuka et al., 2007). Of interest, the speed of centripetal 
TCR MC movement was reported to be ∼40% that of retrograde 
actin flow, indicating significant slippage between cluster move-
ment and actin flow (Kaizuka et al., 2007). As predicted from previ-
ous images of the mature IS, TCR MCs were seen to accumulate at 
the cSMAC, whereas the inward movement of integrin clusters 
ceased at the pSMAC/cSMAC boundary (Kaizuka et al., 2007; 
Hartman et al., 2009). These two observations highlight three im-
portant questions regarding SMAC formation: what molecules link 
receptor clusters to actin flow, what are the physical/mechanical 
properties of this linkage, and how are TCR MCs and integrin clus-
ters sorted at the pSMAC/cSMAC boundary (Hartman and Groves, 
2011)? Regarding the second question, the apparent slippage be-
tween TCR MCs and actin flow observed by Kaizuka et al. (2007) was 
interpreted as evidence that the clusters spend variable periods of 
time completely detached from actin flow, by analogy with the duty 
cycle of a motor protein. Perhaps a more robust interpretation of 
slippage comes from elegant studies employing physical barriers 
placed within bilayers (DeMond et al., 2008; Yu et al., 2010), which 
argue strongly for a dissipative or frictional coupling mechanism in 
which numerous transient, weak interactions between individual re-
ceptors within a cluster and actin keep the cluster attached to actin 
but allows slippage.
Of importance, the peripheral ring of robust actin retrograde 
flow discussed earlier has been shown to lie immediately outside of 
the pSMAC, and as a consequence has been named the distal 
SMAC (dSMAC; Freiberg et al., 2002; Sims et al., 2007). On the 
basis of this observation and of the staining of the IS with various 
antibodies, Dustin (2007) proposed that the IS is in essence a sym-
metric version of the actin cytoskeleton at the front of a migrating 
cell, where the dSMAC corresponds to the lamellipodium (LP) and 
the pSMAC corresponds to the lamellum (LM). Implicit in this com-
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FIGURE 1: Localization of endogenous F-actin structures and corresponding LP/LM markers at the Jurkat IS. 
(A) Phalloidin staining of endogenous F-actin at the IS in representative Jurkat T-cells stimulated on a supported planar 
bilayer (A1, A3) or on a glass coverslip coated with immobilized anti-CD3ε antibody (A5). (A2, A4, A6) Magnified images 
of the boxed regions (white) in A1, A3, and A5, respectively. The central zone, middle ring, and outer ring are indicated 
by brackets above A2, A4, and A6. (B) Overlap in localization of ICAM-1 with the middle ring of F-actin at the IS in a 
representative cell stimulated on a planar bilayer. Note that this image is a single frame from a movie of a cell expressing 
the F-actin reporter GFP–F-tractin-P (see the text) and not an image of a fixed, phalloidin-stained cell, as the distribution 
of ICAM-1 is disrupted by fixation. (B1) ICAM-1, (B3) GFP–F-tractin-P in the same cell, and (B5) merged image between 
B1 (green) and B3 (red). (B2, B4, B6) Magnified images of the boxed regions (white) in B1, B3, and B5, respectively. The 
outer and middle rings are indicated by brackets above B2, B4, and B6. (C) Overlap in localization of TCR MCs with the 
actin-depleted central zone at the IS in a representative cell stimulated on a planar bilayer. (C1) Anti-CD3ε antibody-
labeled TCR MCs, (C2) phalloidin staining in the same cell, and (C3) merged image between C1 (green) and C2 (red). 
(D) Overlap in localization of the Arp2/3 complex with the outer ring of F-actin at the IS in a representative cell 
stimulated on a planar bilayer. (D1) Anti-p34 (Arp2/3 subunit) antibody staining, (D3) phalloidin staining in the same cell, 
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observations are consistent with dynamic ruffling activity at the 
LP/dSMAC and stable substrate adhesion at the LM/pSMAC. Fur-
ther evidence for such ruffling activity in the LP/dSMAC was ob-
tained from three-dimensional reconstructions of phalloidin-stained 
Jurkat cells engaged on bilayers (Figure 1, G1–G3). Specifically, side 
views of F-actin in the LP/dSMAC region (Figure 1, G1, red line) 
show that the F-actin network moves up and down relative to the 
bilayer (Figure 1, G2, red signal; the white line marks the position of 
the bilayer). Conversely, side views of F-actin in the LM/pSMAC re-
gion (Figure 1, G1, green line) show that the F-actin network here is 
always in close contact with the bilayer (Figure 1, G3, green signal). 
We conclude from all of the results in Figure 1 that distinct LP and 
LM F-actin networks exist at the dSMAC and pSMAC regions of the 
IS, respectively, and that the LM/pSMAC is fully engaged at the 
plane of contact, consistent with its role as a zone of adhesion at the 
IS (Figure 1, H1 and H2). Of importance, we show for the first time 
the presence of endogenous F-actin arcs in the LM/pSMAC. We 
also show for the first time that these arcs are rich in endogenous 
myosin IIA. These findings confirm and extend the idea that the 
dSMAC and pSMAC regions of the T cell IS correspond spatially to 
LP and LM F-actin networks, respectively, as proposed by Dustin 
(2007).
A prototype of F-tractin, a novel reporter for F-actin, but 
not GFP-actin, localizes to both LP and LM actin networks 
at the IS
We next sought to visualize the dynamics of F-actin in real time dur-
ing the process of IS formation. Previous imaging studies using GFP-
tagged actin showed convincingly that the dSMAC corresponds to 
a region of dramatic actin polymerization at the leading edge and 
retrograde flow (Bunnell et al., 2001; Kaizuka et al., 2007). That said, 
problems have been encountered with the use of GFP-actin, which 
include exclusion of GFP-actin from specific actin structures (Doyle 
and Botstein, 1996; Wu and Pollard, 2005; Wu et al., 2006), as well 
as aberrations in cytoskeletal architecture and dynamics, especially 
when GFP-actin expression levels are high (Aizawa et al., 1997; 
Westphal et al., 1997). Consistent with such problems, when we 
fixed Jurkat cells expressing moderate levels of GFP-actin after en-
gagement with bilayers and then stained them with Alexa 568–con-
jugated phalloidin, although the F-actin network at the LP/dSMAC 
was clearly visible in both channels as reported previously (Bunnell 
et al., 2001; Kaizuka et al., 2007), the actin arcs at the LM/pSMAC 
were visible only in the phalloidin channel (Figure 2, A1–A6). This 
result, which we observed consistently, argues that GFP-actin does 
not incorporate to a significant extent into the actin arcs that are 
completely with the high concentration of TCR MCs that mark the 
mature cSMAC (Figure 1, C1–C3).
To verify that the outer ring corresponds to the region of dra-
matic actin retrograde flow reported previously (Bunnell et al., 2001; 
Kaizuka et al., 2007), that is, to what is essentially a LP actin network, 
we double stained cells with phalloidin and an antibody against 
p34, a subunit of the Arp2/3 complex and a bona fide marker for the 
LP in migrating cells (Pollard and Borisy, 2003). Figure 1, D1, D3, and 
D5, and the corresponding insets in D2, D4, and D6, show that this 
outer actin ring is indeed rich in the Arp2/3 complex, whereas the 
middle ring is not. This result is consistent with the assignment of 
this outer ring as a LP-like actin network. To verify that the middle 
actin ring corresponds to what is essentially a LM network of F-actin, 
we double stained cells with phalloidin and an antibody against 
nonmuscle myosin IIA, a bona fide marker for the LM in migrating 
cells (Medeiros et al., 2006). Figure 1, E1, E3, and E5, and the cor-
responding insets E2, E4, and E6, show that this middle ring is in-
deed rich in myosin IIA, whereas the outer ring is not. This result is 
consistent with the assignment of this middle ring as a LM-like net-
work of F-actin. Together these results argue that the outer ring, 
which exhibits very intense F-actin staining interrupted by streaks, 
corresponds to a LP actin network (i.e., the dSMAC; Sims et al., 
2007), whereas the middle ring, which comprises concentric actin 
arcs and a high concentration of endogenous myosin IIA and over-
laps extensively with the position of the integrin-rich pSMAC, cor-
responds to a LM actin network. These results confirm and extend 
those of Sims et al. (2007), who used antibodies against cofilin and 
Arp3 as markers for the LP/dSMAC and an antibody against tropo-
myosin as a marker for LM/pSMAC.
Like SMAC formation, the formation of the LP and LM F-actin 
networks was dependent on TCR ligation, as bilayers containing 
only ICAM-1 molecules failed to form these two networks (Supple-
mental Figure S1C). Of importance, Jurkat cells engaged on cover-
slips conjugated with immobilized anti-CD3ε antibody formed the 
two distinct F-actin networks (Figure 1, A5 and A6), indicating that 
the dynamic organization of cortical F-actin at the plane of the IS 
does not require the rearrangement of integrins and TCR MCs that 
drives IS maturation (see also Bunnell et al., 2001).
We also found that phalloidin staining at the LP/dSMAC is usu-
ally most intense in confocal sections just above the lipid bilayer 
(Figure 1, F1–F3; compare in F3 the intensity profiles of phalloidin 
staining across the cell at the plane of the bilayer [F1, low Z, green 
line] vs. 1 μm above the plane of the bilayer [F2, high Z, red line]). 
Conversely, phalloidin staining in the LM/pSMAC was always 
most intense at the plane of the lipid bilayer (Figure 1, F3). These 
and (D5) merged image between D1 (green) and D3 (red). (D2, D4, D6) Magnified images of the boxed regions (white) in 
D1, D3, and D5, respectively. The LP and LM regions are indicated by brackets above D2, D4, and D6. (E) Overlap in 
localization of myosin IIA with the middle ring of F-actin at the IS in a representative cell stimulated on planar bilayer. 
(E1) Anti–myosin IIA antibody staining, (E3) phalloidin staining in the same cell, and (E5) merged image between E1 
(green) and E3 (red). (E2, E4, E6) Magnified images of the boxed regions (white) in E1, E3, and E5, respectively. The LP 
and LM regions are indicated by brackets above E2, E4, and E6. (F) Phalloidin staining at the plane of contact with the 
bilayer (F1) and 1 μm above the plane of contact with the bilayer (F2) in a representative cell stimulated on a planar 
bilayer. (F3) Graph showing the relative intensities of phalloidin fluorescence across the IS for the green line in F1 (and 
the corresponding green intensity trace in F3) and the red line in F2 (and the corresponding red intensity trace in F3). 
The positions of the LP/dSMAC, LM/pSMAC and cSMAC regions are indicated by brackets above F3. (G) Three-
dimensional reconstructed views of phalloidin staining in a representative Jurkat cell stimulated on a planar bilayer. 
(G1) En face view of phalloidin fluorescence at the plane of contact with the bilayer. (G2) Cross-sectional view of 
phalloidin fluorescence in the LP/dSMAC region (corresponding to the red line in G1). (G3) Cross-sectional view of 
phalloidin fluorescence in the LM/pSMAC region (corresponding to the green line in G1). (H) Cartoon of the LP/dSMAC, 
LM/pSMAC, and cSMAC regions at the IS shown from an en face view (H1) and a side view (H2). Scale bars, 5 μm.
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F-actin with modest affinity (∼7 μM) and that 
they have little effect on the rate of depo-
lymerization of preformed actin filaments 
(Johnson and Schell, 2009). Both of these 
properties are desirable for a dynamic F-ac-
tin reporter, as they should increase the 
chance that the reporter exhibits minimal ef-
fects on the organization and dynamics of 
the F-actin structures it seeks to report. Con-
sistently, FRAP of F-actin structures in living 
cells that were labeled with a GFP-tagged 
version of IPTKA peptide 2–66 showed that 
the reporter turns over very rapidly (half-
time of recovery, ∼0.3 s; Johnson and Schell, 
2009). Although the F-actin–binding domain 
of ITPKA has recently been further truncated 
to residues 9–40 and given the name F-trac-
tin (Michael Schell, Uniformed Services Uni-
versity of the Health Sciences, Bethesda, 
MD, personal correspondence), the slightly 
longer 9–52 peptide has already been 
shown to be an excellent in vivo reporter for 
F-actin in two types of neurons (Johnson 
and Schell, 2009; Wagner et al., 2011). Be-
cause peptide 9–52 is in essence a proto-
type of F-tractin and we used this slightly 
longer version throughout this study, we will 
refer to it throughout the text as F-tractin-P.
To begin to validate the use of F-tractin-
P in Jurkat T cells, we fused it to monomeric 
GFP (mGFP), expressed it in cells, fixed the 
cells 5 min after they had contacted the bi-
layer, and stained them with Alexa 568–con-
jugated phalloidin. In striking contrast to the 
results described using GFP-actin, the actin 
arcs in the LM/pSMAC were clearly visible 
in both the green and red channels in cells 
expressing mGFP–F-tractin-P (Figure 2, 
B1–B6). Given that any molecule or peptide 
that binds F-actin, even weakly, like F-trac-
tin-P, should in principle shift the equilibrium 
from G-actin to F-actin to at least some ex-
tent, we performed a number of control ex-
periments to exclude the possibility that the 
expression of F-tractin-P in Jurkat cells in-
duces nonphysiological actin structures or 
significantly alters F-actin dynamics at the 
IS. First, mGFP–F-tractin-P had no obvious 
effect on the total amount of F-actin in cells 
across a broad range of mGFP–F-tractin-P 
expression levels (Supplemental Figure S2A). Consistently, Supple-
mental Figure S2B shows that the average intensity of cellular phal-
loidin staining in all of the cells plotted in Supplemental Figure S2A 
(mGFP–F-tractin-P) was not significantly different from that of con-
trol cells expressing various levels of free mGFP (control GFP; 
p > 0.05). These results argue that even relatively high levels of ex-
pression of mGFP–F-tractin-P that are significantly beyond what is 
necessary to track F-actin in living cells, and beyond the level of 
expression in cells we routinely imaged for data collection, do not 
significantly drive the formation of additional F-actin in cells. Sec-
ond, expression of mGFP–F-tractin-P does not appear to artificially 
stabilize actin filaments in vivo, as F-actin structures labeled by 
present as endogenous structures in the LM/pSMAC (Figure 1). 
Consistent with our observations, no previous study of actin dynam-
ics in T cells using GFP-actin reported the existence of actin arcs or 
rings in the LM/pSMAC.
In light of these observations, we decided to try an alternative to 
GFP-actin to visualize the dynamics of F-actin at the IS. Recently the 
F-actin targeting domain of the enzyme inositol trisphosphate 
3-kinase A (ITPKA), which phosphorylates inositol 1,4,5-trisphosphate 
to inositol 1,3,4,5-tetrakisphosphate in the dendritic spines of hip-
pocampal neurons, was reported to bind F-actin both in vitro and in 
vivo (Johnson and Schell, 2009). Specifically, in vitro assays showed 
that peptides corresponding to residues 2–66 or 9–52 of ITPKA bind 
FIGURE 2: Comparison of F-actin structures at the IS reported by GFP-actin and mGFP–F-
tractin-P. (A) F-Actin structures reported at the IS by GFP-actin and phalloidin in a representative 
Jurkat cell fixed after engagement on a planar bilayer. (A1) GFP-actin, (A2) phalloidin staining in 
the same cell, and (A3) merged image between A1 (green) and A2 (red). (A4–A6) Magnified 
images of the boxed regions (white) in A1–A3, respectively. (B) F-Actin structures at the IS 
reported by GFP–F-tractin-P and phalloidin in a representative Jurkat cell fixed after stimulation 
on a planar bilayer. (B1) GFP–F-tractin-P, (B2) phalloidin staining in the same cell, and (B3) 
merged image between B1 (green) and B2 (red). (B4–B6) Magnified images of the boxed regions 
(white) in B1–B3, respectively. The positions of the LP/dSMAC and LM/pSMAC regions of the IS 
are indicated by the brackets above A4–A6 and B4–B6. Scale bars, 5 μm.
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mGFP–F-tractin-P were rapidly depolymer-
ized by the addition of 10 μM latrunculin A 
(Supplemental Figure S2C). Specifically, in 
cells expressing mGFP–F-tractin-P, where 
depolymerization was gauged by watching 
in real time the disappearance of mGFP–F-
tractin-P–labeled structures (Supplemental 
Figure S2C), as well as in untransfected cells 
and cells treated with just DMSO (the vehi-
cle for latrunculin), where depolymerization 
was gauged by fixation and staining with 
phalloidin at various time points (data not 
shown), the depolymerization of F-actin 
structures was very obvious at ∼30 s after 
latrunculin addition and nearly complete at 
∼60 s. Finally, Jurkat cells expressing F-trac-
tin-P tagged with tdTomato showed the 
same extent of calcium influx upon contact 
with the stimulatory lipid bilayer as control 
cells (Supplemental Figure S2, D and E; 
compare the control cell in D1–D3, with 
the cell expressing tdTomato-F-tractin-P in 
E1–E3). This observation argues that down-
stream TCR signaling is not altered by the 
expression of F-tractin-P. In summary, these 
controls, together with the crucial fact that 
mGFP–F-tractin-P, but not GFP-actin, labels 
the actin arcs in the LM/pSMAC that are 
present as endogenous structures in phalloi-
din-stained, untransfected cells, lead us to 
conclude that F-tractin-P is an ideal reporter 
for visualizing the dynamics of F-actin in 
both the LP and LM actin networks at the 
Jurkat IS.
Quantitation of F-actin dynamics using 
F-tractin-P reveals a striking difference 
in centripetal flow rates between the 
LP/dSMAC and the LM/pSMAC
Having established from fixed cell images 
that the LP/dSMAC and LM/pSMAC pos-
sess distinct organizations of F-actin, we 
next asked whether the dynamics of F-actin 
in these two regions also differ. To address 
this question, we took time-lapse images of 
Jurkat T cells expressing mGFP–F-tractin-P 
after engagement on the planar bilayer 
(Figure 3, A1–A3; unless indicated other-
wise, all dynamic imaging was initiated 
2 min after loading cells into the bilayer; 
see also Materials and Methods). In agree-
ment with previous reports (Bunnell et al., 
2001; Kaizuka et al., 2007), dramatic 
actin retrograde flow was observed in the 
FIGURE 3: Characterization of F-actin dynamics in the LP/dSMAC and LM/pSMAC regions of 
the IS. (A) Centripetal actin flow in the LP/dSMAC and LM/pSMAC regions of the IS observed 
using GFP–F-tractin-P in a representative Jurkat cell stimulated on a planar lipid bilayer (see also 
Supplemental Movie S1). (A1) F-Actin reported by GFP–F-tractin-P at the IS. (A2, A3) Kymograph 
of GFP–F-tractin-P in the region corresponding to the yellow line in A1, shown in low contrast 
(A2) and high contrast (A3). In this and all subsequent kymographs, the shallower the slope, the 
faster is the speed, and the steeper the slope, the slower is the speed. Dotted yellow lines were 
added to demonstrate the distinct slopes in the LP/dSMAC (A2) and LM/pSMAC (A3). 
(B) Centripetal flow of F-actin and myosin IIA at the IS in a representative cell engaged on a 
bilayer (see also Supplemental Movie S3). (B1) tdTomato–F-tractin-P, (B2) GFP–myosin IIA HC in 
the same cell, and (B3) merged image between B1 (red) and B2 (green). (B4–B6) Magnified 
images of the boxed regions (orange) in B1–B3, respectively. White arrowheads indicate two 
arcs present in the LM/pSMAC that clearly possess both F-actin and myosin IIA. (B7) Low-
contrast kymograph of tdTomato–F-tractin-P in the region corresponding to the yellow line in 
B1. (B8) High-contrast kymograph of tdTomato–F-tractin-P in the region corresponding to the 
yellow line in B1. (B9) Kymograph of GFP–myosin IIA HC in the region corresponding to the 
yellow line in B2. Dotted yellow lines were added to highlight identical arc movement in the 
LM/pSMAC observed using Tomato–F-tractin-P (B8) and GFP–myosin IIA-HC (B9). The positions 
of the LP/dSMAC and LM/pSMAC regions of 
the IS are indicated by the brackets above 
A2, A3, B4–B6, and B7–B9. The time scales 
(in seconds) for all of the kymographs shown 
are indicated on the left. Scale bars in A1 and 
B3, 5 μm; in A2, A3, and B7, 2 μm.
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LP/dSMAC region, as evidenced by kymograph images across this 
region (Figure 3, A2, low contrast, LP/dSMAC; see also Supple-
mental Movie S1). Moreover, the rate of retrograde flow across the 
LP/dSMAC appears both uniform and constant, as evidenced by 
the uniformity and linearity in the slopes that comprise the portion 
of kymographs corresponding to this zone.
Even more important, mGFP–F-tractin-P revealed that the con-
centric actin arcs observed in the LM/pSMAC of untransfected cells 
stained with phalloidin (Figure 1) and in still images of cells trans-
fected with mGFP–F-tractin-P (Figure 2) are highly dynamic. Specifi-
cally, they form at the boundary between the LP/dSMAC and LM/
pSMAC, move inward across the LM/pSMAC, as evidenced by 
kymograph images across this region (Figure 3, A3, high contrast, 
LM/pSMAC; see also Supplemental Movie S1), and then disappear 
abruptly at the boundary between the LM/pSMAC and the cSMAC. 
Moreover, the rate of movement of these actin arcs across the pS-
MAC appears both uniform and constant, as evidenced by the uni-
formity and linearity in the slopes that comprise the portion of 
kymographs corresponding to this zone.
Visual inspection of both kymographs and movies obtained 
from individual cells like the one shown in Figure 3A argue that 
the rates at which the distinct F-actin networks in the LP/dSMAC 
and LM/pSMAC move inward must be quite different. Consis-
tently, measurements made using kymographs obtained from 
eight cells yielded a value of 0.105 ± 0.006 μm/s for the average 
rate of retrograde actin flow across the LP/dSMAC and 0.037 ± 
0.003 μm/s for the average rate of centripetal actin arc move-
ment across the LM/pSMAC (in Figure 5A later in the paper, com-
pare LP/dSMAC wild-type [WT] actin to LM/pSMAC WT actin; 
p < 0.001). In addition to this approximately threefold difference 
in centripetal flow rate, we note that the transition between these 
two flow rates occurs quite abruptly at the boundary between the 
LP/dSMAC and LM/pSMAC (Figure 3, A1–A3). Finally, we note 
that essentially identical rates of actin retrograde flow and cen-
tripetal actin arc movement were observed when Jurkat cells ex-
pressing mGFP–F-tractin-P were engaged on coverslips coated 
with immobilized anti-CD3ε antibody (Supplemental Figure S3A; 
see also Supplemental Movie S2). This result indicates that the 
dynamics of the two distinct actin networks in the LP and LM, as 
well as their formation (see Figure 1), does not require the rear-
rangement of integrin and TCR clusters that drives IS maturation 
(see also Bunnell et al., 2001). Together these data indicate that 
the LP/dSMAC and LM/pSMAC regions possess organizations of 
F-actin that are kinetically as well as structurally distinct.
Myosin IIA moves inward with the actin arcs in the LM/
pSMAC
Given that the mGFP–F-tractin-P–labeled actin arcs in the LM/pS-
MAC undergo apparent contraction, as observed for myosin II–con-
taining actin arcs in the LM of migrating cells (Gupton and Water-
man-Storer, 2006; Medeiros et al., 2006) and that the LM/pSMAC 
stains extensively for endogenous myosin IIA (Figure 1E), we next 
asked whether these actin arcs colocalize with myosin IIA in living 
cells. To accomplish this, we cotransfected Jurkat cells with tdTo-
mato–F-tractin-P and the heavy chain of myosin IIA fused at its N-
terminus to GFP (GFP–myosin IIA HC), and we imaged the cells after 
engagement on bilayers. As in the preceding figure using mGFP–F-
tractin-P, tdTomato–F-tractin-P reported the two structurally (Figure 3, 
B1, and the inset in B4) and kinetically (Figure 3, B7 and B8; see low 
contrast for the LP/dSMAC and high contrast for the LM/pSMAC) 
distinct zones of F-actin in the LP/dSMAC and LM/pSMAC (see also 
Supplemental Movie S3). With regard to the signal for myosin IIA, in 
addition to weak fluorescence in the LP/dSMAC, an intense signal 
was observed in the LM/pSMAC (Figure 3, B2, and the inset in B5; 
see also the overlaid images in B3 and B6). Moreover, kymographs 
revealed that this intense signal for myosin IIA, which often has the 
appearance of rings or arcs (Supplemental Movie S3), also moves 
centripetally in the LM/pSMAC zone (Figure 3, B9). Of importance, 
measurements made using kymographs obtained from seven cells 
yielded a value of 0.038 ± 0.001 μm/s for the average rate of cen-
tripetal movement of these myosin IIA–rich structures across the 
LM/pSMAC (Supplemental Figure S3A). This value is not different 
from the average rate of centripetal movement of actin arcs in the 
LM/pSMAC (see Figure 5A later in the paper; p > 0.05). We note that 
the expression of GFP-tagged myosin IIA HC alone (i.e., without 
F-tractin-P) also reports these translocating myosin IIA–rich structures 
in the LM/pSMAC (Supplemental Figure S3, A, B1, and B2; see also 
Supplemental Movie S4). This result argues that these myosin IIA–rich, 
arc-like structures are not induced by our F-actin reporter. Finally, we 
obtained very similar images and rate values when we visualized myo-
sin IIA by tagging its regulatory light chain with GFP (GFP–myosin II 
RLC) instead of its heavy chain (Supplemental Figure S3, A, C1, and 
C2; see also Supplemental Movie S5).
The fact that the region of the Jurkat cell cortex that contains the 
actin arcs, that is, the LM/pSMAC, is also the region that has the 
highest concentration of myosin IIA—both endogenous (Figure 1, 
E1–E6) and exogenous (Figure 3, B1–B6)—suggests that what we 
are actually seeing in this zone are circularized, contracting actomy-
osin IIA bundles. Consistent with this idea, the rates at which 
the actin arcs and the myosin IIA–rich structures move inward in the 
LM/pSMAC are indistinguishable (see prior discussion). Moreover, 
close inspection of the signals for actin and myosin IIA in the LM/
pSMAC shows that in many cases the two signals completely over-
lap in the form of concentric bands or arcs (Figure 3, B4–B6; see 
arrowheads). Finally, time-lapse images of arcs exhibiting variations 
in GFP–myosin IIA HC intensity within the arc show that small re-
gions of increased fluorescence intensity get closer together over 
time, consistent with arc contraction (Supplemental Figure S3, D1 
and D2). We conclude, therefore, that the pSMAC is rich in contract-
ing actomyosin IIA bundles, much like the LM of a crawling cell 
(Medeiros et al., 2006). To our knowledge, this is the first observa-
tion of contracting actomyosin II arcs at the IS in T cells.
TCR microclusters move inward at the speed of actin 
retrograde flow in the LP/dSMAC and at the speed 
of actomyosin IIA arc contraction in the LM/pSMAC
TCR MC transport at the IS requires F-actin (Varma et al., 2006; 
Nguyen et al., 2008). Moreover, numerous studies have pointed to 
actin polymerization and subsequent retrograde flow as the princi-
pal if not sole mechanism driving the centripetal movement of these 
MCs (Kaizuka et al., 2007; DeMond et al., 2008; Yu et al., 2010). That 
said, none of these studies took into account the existence of the 
contracting actomyosin IIA arcs in the LM/pSMAC described here 
earlier. Therefore we next sought to correlate the rates of TCR MC 
movement across the entire IS with the rates of centripetal actin 
movement in the two structurally and kinetically distinct zones of F-
actin at the IS described here. To accomplish this, Jurkat cells ex-
pressing mGFP–F-tractin-P were imaged on bilayers containing 
anti-CD3ε antibody labeled with rhodamine-X to report the position 
of bound TCR MCs in the Jurkat plasma membrane. Movies initi-
ated immediately after the T cell had contacted the bilayer show 
that TCR MCs first appear at the distal edge of the cell, at which 
point they then move inward at a near constant speed and in a rela-
tively linear path across the entire LP/dSMAC (Figure 4A, frames 
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sentative cell, where tracks across the LP/dSMAC and LM/pSMAC 
are color coded red and green, respectively. To determine the 
rates of TCR MC transport, we manually tracked MCs and calcu-
lated their instantaneous, frame-to-frame velocities (see Materials 
and Methods for details). To determine the rates of retrograde 
actin flow and actin arc contraction, we measured the slopes in 
kymographs of the mGFP–F-tractin-P signal. Consistent with the 
aforementioned conclusions, the average instantaneous velocity 
of centripetal TCR MC movement across the LP/dSMAC (0.094 ± 
0.016 μm/s) was not statistically different from that of actin retro-
grade flow in this zone (0.105 ± 0.006 μm/s; Figure 5A, compare 
LP/dSMAC WT actin to LP/dSMAC WT TCR; p > 0.05). Likewise, 
the average instantaneous velocity of centripetal TCR MC move-
ment across the LM/pSMAC (0.038 ± 0.006 μm/s) was not statisti-
cally different from that of actin arc contraction in this zone 
(0.037 ± 0.003 μm/s; Figure 5A; compare LM/pSMAC WT actin to 
LM/pSMAC WT TCR; p > 0.05). Together these results argue 
strongly that the centripetal movements of TCR MCs at the IS are 
driven sequentially by rapid retrograde actin flow in the LP/dSMAC 
and slower, contracting, actomyosin IIA arcs in the LM/pSMAC. 
These results also argue that the coupling between the centripe-
tal movement of TCR MCs and the retrograde movement of 
F-actin is much less dissipative than previously reported (Kaizuka 
et al., 2007; see Discussion).
0–40 s; see arrowheads; see also Supplemental Movie S6). More-
over, comparison of the kymographs for actin retrograde flow and 
the movement of individual MCs across the LP/dSMAC (Figure 4, 
B1–B3, LP/dSMAC) show that these two rates closely match through-
out this zone. Even more strikingly, upon entering the LM/pSMAC 
zone, the movement of TCR MCs slows abruptly (Figure 4A, frames 
40–90 s; see arrowheads; see also Supplemental Movie S6). In other 
words, upon entering the LM/pSMAC, the centripetal movement of 
TCR MCs appears to decrease abruptly to match that of the slower-
contracting actomyosin IIA arcs in this zone. Consistent with this 
conclusion, comparison of kymographs for actin arc contraction and 
the movement of individual TCR MCs across the LM/pSMAC 
(Figure 4, B1–B3, LM/pSMAC) show that these two rates closely 
match throughout this zone. These results suggest, therefore, that 
there is fairly precise spatial and kinetic coupling between the cen-
tripetal movements of TCR MCs and F-actin in both the LP/dSMAC 
and LM/pSMAC. This in turn argues that TCR MCs are tightly cou-
pled to the rapid retrograde actin flow in the LP/dSMAC and to the 
slower, contracting, actomyosin IIA arcs in the LM/pSMAC.
To provide quantitative support for the foregoing conclusions, 
we next measured the rates of centripetal TCR MC movement 
and centripetal actin flow across both the LP/dSMAC and LM/
pSMAC in 15 Jurkat cells engaged on bilayers and imaged every 
4 s. Figure 4C shows the paths of all of the TCR MCs in a repre-
FIGURE 4: Characterization of TCR MC dynamics at the LP/dSMAC and LM/pSMAC regions of the IS. (A) Time-lapse 
images showing TCR MC movements in the LP/dSMAC and LM/pSMAC regions of the IS in a representative Jurkat cell 
stimulated on a planar bilayer (see also Supplemental Movie S6). TCR MCs (pseudocolored green) reported by 
rhodamine X–labeled anti-CD3ε antibody in the bilayer. F-Actin (pseudocolored red) reported by GFP–F-tractin-P. White 
arrowheads point to a TCR MC undergoing inward movement. The frame at 40 s that is boxed in orange indicates the 
moment when this TCR MC moved from the LP/dSMAC into the LM/pSMAC during its centripetal movement. (B1) 
Kymograph of GFP–F-tractin-P in the region corresponding to the yellow line in A (0 s), (B2) kymograph of a TCR MC in 
the region corresponding to the yellow line in A (0 s), and (B3) merged image between B1 (red) and B2 (green). The 
positions of the LP/dSMAC and LM/pSMAC regions of the IS are indicated by the brackets above B1–B3. The boundary 
between the LP/dSMAC and LM/pSMAC is indicated by the orange line in B1–B3. The time scale of the kymographs in 
B1–B3 is indicated to the left of B1. (C) Paths of all visible TCR MCs in a representative Jurkat cell stimulated on a planar 
bilayer. TCR MC paths in the LP/dSMAC are shown in red, and TCR MC paths in the LM/pSMAC are shown in green. 
The paths are discontinuous because we purposely avoided making measurements at the dSMAC/pSMAC boundary. 
(D) Spatial and kinetic relationship between a TCR MC and surrounding actomyosin II arcs in the LM/pSMAC region of 
the IS (see also Supplemental Movie S7). (D1) GFP–myosin IIA HC (pseudocolored red) and TCR MCs (pseudocolored 
green) at the IS of a Jurkat cell stimulated on a planar bilayer. (D2) Magnified image of the boxed region (white) in D1. 
(D3) Relative intensities for myosin IIA (red) and a TCR MC (green) across the yellow line in D2. (D4) Kymograph of two 
prominent myosin IIA-containing arcs in the region corresponding to the yellow line in D1, (D5) kymograph of a TCR MC 
in the region corresponding to the yellow line in D1, and (D6) merged image between D4 (red) and D5 (green). The time 
scale of the kymographs in D4–D6 is indicated to the right of D6. Scale bars in A, B3, and D6, 2 μm; in D1, 5 μm.
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To further investigate the precise spa-
tial relationship within the LM/pSMAC be-
tween the centripetal movement of TCR 
MCs and the inward movement of the 
contracting actomyosin IIA arcs, we im-
aged TCR MCs movements in Jurkat cells 
expressing GFP–myosin IIA HC (Figure 4, 
D1; see also Supplemental Movie S7). 
Two-color line scans (Figure 4, D3) across 
individual, green TCR MCs in the LM/pS-
MAC (Figure 4, D2) of a typical cell 
(Figure 4, D1) show that the peak of fluo-
rescence intensity for the MC usually falls 
between two peaks of fluorescence inten-
sity for myosin IIA arcs. Moreover, two-
color kymographs show that MCs con-
tinue to localize over time between the 
successive, contracting, actomyosin IIA 
arcs (Figure 4, D4–D6; see arrowheads). 
Of 100 TCR MCs picked at random, 71 fell 
between myosin IIA arcs based on both 
visual inspection and line scans, arguing 
that this phenomenon is common. These 
observations, together with the fact that 
TCR MCs move in tandem with the con-
tracting actomyosin IIA arcs in the LM/
pSMAC (Figure 5A), raise the possibility 
that MC transport across this zone is 
driven by a “sweeping” motion gener-
ated by the actomyosin IIA arcs, although 
this does not preclude either direct or in-
direct physical interactions between the 
MCs and the arcs.
Inhibition of myosin IIA with 
blebbistatin slows TCR MC movement 
in the LP/dSMAC and disrupts both 
the organization of actin arcs and 
the directed transport TCR MCs 
in the LM/pSMAC
Given the tight coupling within the LM/pS-
MAC between the centripetal movement of 
TCR MCs and the apparent contraction of 
actomyosin IIA arcs, we next sought to mea-
sure the contribution made by myosin IIA to 
the organization of F-actin and the transport 
of MCs in this region of the IS. More specifi-
cally, we sought to examine in detail the ef-
fects of conditionally inhibiting myosin IIA 
on the rates of centripetal actin flow and 
TCR MC movement in both the LP/dSMAC 
and LM/pSMAC using bilayer-engaged Jur-
kat cells expressing tdTomato–F-tractin-P. 
To inhibit myosin IIA rapidly and selectively, 
we used 50 μM blebbistatin (BB), a cell-per-
meable and highly specific inhibitor of myo-
sin IIA’s ATPase activity (Allingham et al., 
2005) that locks the myosin in a weakly 
bound, ADP-Pi state, causing it to dissoci-
ate from F-actin. In all experiments, Jurkat 
cells were engaged with the bilayer follow-
ing a 30-min preincubation with BB at 37°C. 
FIGURE 5: Effect of blebbistatin on the dynamics of F-actin and TCR MCs in the LP/dSMAC and 
LM/pSMAC regions of the IS. (A) Graph showing the rates of centripetal movement (in μm/s) of 
actin (red) and TCR MCs (green) in the LP/dSMAC and LM/pSMAC regions of WT (in this study, 
WT is used to indicate untreated cells) and BB-, CD-Jas–, and CD-Jas-BB–treated Jurkat cells 
stimulated on planar bilayers. The bars indicate the mean and SD for the centripetal rate. The 
number of cells analyzed for each measurement is indicated inside (or above) the bar (∼50 TCR 
MCs were measured per cell). (B) Graph showing the meandering index (net displacement/total 
distance traveled) of TCR MCs measured in the LP/dSMAC and LM/pSMAC region of WT and 
BB- and CD-Jas–treated cells. Each bar shows the mean and SD for the meandering index. The 
number of cells analyzed for each measurement is indicated inside the bar. (C) Graph showing 
the percentage of TCR MCs that moved one or more pixels (black) or zero pixels (gray) per 
frame in the LP/dSMAC and LM/pSMAC regions of WT and BB-, CD-Jas–, and CD-Jas-BB–
treated cells. The bars show the percentages of all measurements that fall in these two 
categories. (D) The effect of BB on the dynamics of actin arcs and the movements of TCR MCs in 
the LM/pSMAC region of the IS (see also Supplemental Movie S8). (D1) tdTomato–F-tractin-P at 
the IS in a BB-treated cell stimulated on a planar bilayer. (D2) Time-lapse images of the boxed 
region (white) in D1. The yellow arrowheads point to a buckling actin arc in the LM/pSMAC. 
(D3) Kymograph of Tomato–F-tractin-P in the region corresponding to the yellow line in D1, 
(D4) kymograph of TCR MCs in the region corresponding to the yellow line in D1, and (D5) 
merged image between D3 (red) and D4 (green). The positions of the LP/dSMAC and LM/
pSMAC regions of the IS are indicated by the brackets above D3–D5. The time scale of the 
kymographs in D3–D5 is indicated to the right of D5. Scale bar in D1, 5 μm; in D4, 2 μm.
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We took special care to avoid the use of blue light, which rapidly 
inactivates BB (Sakamoto et al., 2005).
For Jurkat cells treated for 30 min with DMSO (the vehicle for 
BB), the rates of centripetal actin flow and TCR MC movement in 
both the LP/dSMAC and LM/pSMAC were not statistically different 
from the rates in untreated cells (Supplemental Figure S3A; 
p > 0.05). In contrast, BB treatment led to a 44.4% reduction in the 
average speed of actin retrograde flow across the LP/dSMAC re-
gion, from 0.105 ± 0.006 to 0.058 ± 0.010 μm/s (Figure 5A; com-
pare LP/dSMAC WT actin to LP/dSMAC BB Actin; p < 0.001). This 
result is consistent with the effect of BB on the rate of actin retro-
grade flow in the LP of other cell types (Medeiros et al., 2006; 
Wilson et al., 2010) and is presumably due to a BB-induced reduc-
tion in the pulling force within the LM (see later discussion). In par-
allel with this reduction in the rate of actin retrograde flow, the av-
erage rate of centripetal TCR MC movement in the LP/dSMAC was 
reduced by 44.2% following BB treatment, from 0.094 ± 0.016 to 
0.052 ± 0.006 μm/s (Figure 5A; compare LP/dSMAC WT TCR to LP/
dSMAC BB TCR; p < 0.001). The directionality of TCR MC move-
ments in the LP/dSMAC of BB-treated cells, as measured using the 
“meandering index” (total distance/net displacement; see Materi-
als and Methods) was not, however, significantly different from that 
in WT (Figure 5B; compare LP/dSMAC WT to LP/dSMAC BB; 
p > 0.05). Together these results argue that although myosin IIA 
contributes to efficient actin retrograde flow and TCR MC move-
ment in the LP/dSMAC, presumably as a consequence of its crucial 
role in generating via actin arc contraction a pulling force within the 
LM/pSMAC (Vicente-Manzanares et al., 2009; also see later discus-
sion), it is not essential for the directed/persistent movement of 
TCR MCs in the LP/dSMAC. We also note that the rates of actin 
retrograde flow and inward TCR MC movement across the LP/dS-
MAC of BB-treated cells remain tightly coupled, as these two rates 
are not statistically different (compare LP/dSMAC BB actin to LP/
dSMAC BB TCR in Figure 5A; p > 0.05).
With regard to the effects of BB treatment on the rates of actin 
arc contraction and centripetal TCR MC movement in the 
LM/pSMAC, the initial and most striking observation was that BB 
disrupted the organization of the concentric actin arcs found in this 
zone (Figure 5, D1–D5; also see Supplemental Movie S8). Specifi-
cally, BB treatment changed the organization of these actin arcs 
from the fairly ordered pattern of concentric rings seen in WT 
(Figures 1–3) and DMSO-treated control cells (data not shown) to 
one in which the arcs appear loose, disorganized, and not strongly 
concentric (Figure 5, D1). Moreover, time-lapse imaging shows that 
the actin arcs in BB-treated cells tend to buckle and deform due to 
the pushing force exerted by continued actin retrograde flow in the 
LP/dSMAC region (Figure 5, D2; see arrowheads; see also Supple-
mental Movie S8). These defects in arc behavior are also evident in 
kymographs of centripetal actin flow in BB-treated cells (Figure 5, 
D3, LM/pSMAC), where individual slopes that span the LM/pSMAC 
are not uniform across this zone, as compared with actin arcs in un-
treated cells (compare the LM/pSMAC actin kymograph for the 
BB-treated cell in Figure 5, D3, to the LM/pSMAC actin kymograph 
for the WT cell in Figure 3, A3). These defects in actin arc organiza-
tion and dynamics are very evident when one compares movies of 
untreated and BB-treated cells side by side, where the disorganized 
and nonuniform inward movement of arcs in the LM/pSMAC of 
BB-treated cells contrasts sharply with the relatively uniform inward 
progression of actin arcs in the LM/pSMAC of untreated cells (see 
Supplemental Movie S8, BB treated; Supplemental Movie S1, WT).
With regard to the quantitative effect of BB treatment on the rate 
of actin arc contraction in the LM/pSMAC, the drug reduced this 
rate by 43.2%, from 0.037 ± 0.003 to 0.021 ± 0.003 μm/s; Figure 5A; 
compare LM/pSMAC WT actin to LM/pSMAC BB actin; p < 0.001; 
note that this measurement used only the centripetal and nonverti-
cal [i.e., moving] portions of individual slopes in the kymographs; 
see Materials and Methods for more details). In parallel with this re-
duction in the rate of actin arc contraction in the LM/pSMAC, the 
average rate of centripetal TCR MC movement in this zone was re-
duced following BB treatment by 34.2%, from 0.038 ± 0.006 to 
0.025 ± 0.005 μm/s; Figure 5A; compare LM/pSMAC WT TCR to 
LM/pSMAC BB TCR; p < 0.002). Moreover, the percentage of total 
TCR MC frames recorded where individual MCs did not advance by 
at least one pixel per frame is much higher in the LM/pSMAC region 
of BB-treated cells (60%) than in the LM/pSMAC region of control 
cells (6%; Figure 5C). This observation reveals a pronounced in-
crease in the frequency of very slow displacements or pauses in the 
inward transport of TCR MCs across the LM/pSMAC with BB treat-
ment. Because these “pauses” were not included in the analysis of 
TCR MC rates, the data in Figure 5A underestimate to some extent 
the magnitude of the decrease in inward TCR MC movement across 
the LM/pSMAC of BB-treated cells. The directionality of TCR MC 
movements in the LM/pSMAC of BB-treated cells was also signifi-
cantly degraded relative to that in WT cells (Figure 5B; compare 
LM/pSMAC BB to LM/pSMAC WT; p < 0.001). Finally, two-color 
kymographs (Figure 5, D3–D5) show that the paths of TCR MCs in 
the LM/pSMAC of BB-treated cells follow in zigzag manner the con-
voluted paths of the inwardly moving actin arcs. Together these re-
sults argue that although myosin IIA is not absolutely essential for 
the inward movement of actin arcs and TCR MCs across the LM/
pSMAC, the myosin does make a major contribution to the overall 
organization and inward movement of the actin arcs and conse-
quently to the speed and directional persistence of centripetal TCR 
MC movements across the LM/pSMAC. Moreover, just as the ro-
bustness of retrograde actin flow and coupled MC movement in the 
LP/dSMAC depends on the pulling force provided by actomyosin 
II–driven contraction in the LM/pSMAC (see earlier discussion), we 
believe that the persistence of some inward actin arc movement and 
coupled MC movement in the LM/pSMAC in the absence of myosin 
II–driven contraction is due to the persistence of the actin retro-
grade flow–driven pushing force in the LP/dSMAC. Indeed, this 
pushing force, and the degree to which it pushes the flaccid actin 
arcs in the LM/pSMAC of a BB-treated cells inward, is very clear in 
Supplemental Movie S8. We note that the rates of actin retrograde 
flow and inward TCR MC movement across the LM/pSMAC of BB-
treated cells remain coupled, as these two rates are not statistically 
different (compare LM/pSMAC BB actin to LM/pSMAC BB TCR in 
Figure 5A; p > 0.05). We also note that myosin IIA, as visualized us-
ing its RLC tagged with mRFP, does not colocalize with the disorga-
nized actin arcs present in BB-treated cells, consistent with the mode 
of action of this inhibitor (data not shown).
Of interest, the region in the center of the IS that is normally 
largely devoid of F-actin and corresponds to the cSMAC was no 
longer visible in BB-treated cells (Figure 5, D1). This observation is 
consistent with the proposed role for myosin II in the severing of LM 
actin bundles and the subsequent disassembly of the LM actin net-
work (Medeiros et al., 2006; Wilson et al., 2010).
Inhibition of actin retrograde flow causes the F-actin 
network and associated TCR MCs in the LP/dSMAC to 
retract at a speed that corresponds to slowed actomyosin II 
arc contraction in the LM/pSMAC
To gauge the relative contribution of actin polymerization–driven 
retrograde flow to TCR MC transport across the IS, we sought to 
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selectively inhibit the polymerization of F-actin at the distal edge of 
the LP/dSMAC using cytochalasin D (CD), a membrane-permeable 
molecule that tightly caps (Kd = 0.5 nM) the fast-growing, free barbed 
end of the actin filament, preventing further filament elongation 
(Carlier et al., 1986). In previous studies, 1–5 μM CD was shown to 
cause the rapid and complete retraction of the LP actin network in 
numerous cell types (Forscher and Smith, 1988; Henson et al., 1999). 
Moreover, in newt lung cells, low-dose CD (0.1–0.5 μM) was shown to 
selectively disrupt actin retrograde flow in the LP while having no 
obvious effect on the rate of actomyosin II–driven flow in the LM 
(Ponti et al., 2004). In an effort to replicate these effects in Jurkat T 
cells, we initially tested different concentra-
tions of CD on cells expressing mGFP–F-trac-
tin-P and engaged on coverslips coated with 
anti-CD3ε antibody. Concentrations of CD of 
>0.5 μM caused cells to rapidly round up, 
making imaging impossible (data not shown). 
Conversely, CD concentrations of ≤0.1 μM 
had little immediate effect on the cells. At a 
CD concentration of 0.2 μM, however, a sig-
nificant fraction of the F-actin network in the 
LP/dSMAC retracted within 4 min (compare 
the signals for GFP–F-tractin-P before treat-
ment with CD [Figure 6, A1] to that 4 min af-
ter CD addition [Figure 6, A2]; see also Sup-
plemental Movie S9). The time course of this 
effect was rapid, as retraction of actin in the 
LP/dSMAC began almost immediately after 
CD addition. This is shown by the kymograph 
in Figure 6, A3, which was taken from the re-
gion of the LP/dSMAC highlighted by the 
yellow line in A2 (the time when CD was 
added is marked by the black arrowhead, 
and the time when retraction began is 
marked by the orange arrowhead). More-
over, the contraction of actomyosin II arcs in 
the LM/pSMAC continued uninterrupted for 
up to 5 min after addition of low-dose CD 
(see the LM/pSMAC region in the kymograph 
in Figure 6, A3; see also Supplemental Movie 
S9). Although these observations are reminis-
cent of the effect of CD on newt lung cells 
(Ponti et al., 2004), the inhibition of actin ret-
rograde flow in the LP/dSMAC of these CD-
treated Jurkat cells was far from complete. 
Specifically, as portions of the actin network 
comprising the LP/dSMAC began to retract, 
a large number of spike-like F-actin-rich 
structures were left behind (Figure 6, A2). In 
addition, the actin in these spikes continued 
to undergo actin treadmilling, as evidenced 
by the slopes in the kymograph in Figure 6, 
A4, which was taken from the region of the 
LP/dSMAC highlighted by the red line in A2 
that spans one of these F-actin spikes.
We next sought an alternative to CD 
to inhibit actin retrograde flow in the LP/
dSMAC more completely. In the previous 
study by Ponti et al. (2004), the addition of 
1 μM jasplakinolide (Jas), a cell-permeable 
molecule that stabilizes actin filaments, was 
shown to block actin retrograde flow in the 
LP without significantly disrupting myosin II–driven actin flow in the 
LM. Jas is believed to inhibit actin retrograde flow in the LP by block-
ing the depolymerization of F-actin on the back side of the LP, leading 
to the rapid depletion of a pool of G-actin used preferentially to sup-
port polymerization at the leading edge (Cramer, 1999; Ponti et al., 
2004). As with CD, we initially tested different concentrations of Jas 
on Jurkat cells expressing mGFP–F-tractin-P and engaged on cover-
slips coated with anti-CD3ε antibody. Concentrations of Jas of 1 μM 
or greater caused cells to rapidly round up, making imaging difficult 
(data not shown). The addition of 0.5 μM Jas, however, caused the 
complete retraction of the actin network in the LP/dSMAC within 
FIGURE 6: Testing the effects of CD, Jas, and CD-Jas treatments on actin retrograde flow in 
cells engaged on coverslips. (A) Effect of low-dose CD on the organization and dynamics of 
F-actin at the IS in a Jurkat cell stimulated on a coverslip substrate (see also Supplemental Movie 
S9). (A1) GFP–F-tractin-P at the IS before addition of low-dose CD. (A2) GFP–F-tractin-P at the IS 
of this same cell 4 min after addition of low-dose CD. (A3) Kymograph of GFP–F-tractin-P in the 
region corresponding to the yellow line in A2. (A4) Kymograph of GFP–F-tractin-P in the region 
corresponding to the red line in A2. The black and orange arrowheads in these two kymographs, 
as well as those in B4 and C4, mark the time when CD and/or Jas was added and when the LP 
network began to retract, respectively. (B) Effect of Jas on the organization and dynamics of 
F-actin at the IS in a Jurkat cell stimulated on a coverslip substrate (see also Supplemental Movie 
S10). (B1) GFP–F-tractin-P at the IS before addition of Jas. (B2) GFP–F-tractin-P at the IS in this 
same cell 4 min after addition of Jas. (B3) GFP–F-tractin-P at the IS in this same cell 6 min after 
addition of Jas. The pronounced rings of F-actin that accumulate following Jas addition at the 
boundary between LP/dSMAC and LM/pSMAC, and at the boundary between the LM/pSMAC 
and cSMAC, are indicated by the red and green arrowheads, respectively. (B4) Kymograph of 
GFP–F-tractin-P in the region corresponding to the yellow line in B2. (C) Effect of CD-Jas on the 
organization and dynamics of F-actin at the IS in a Jurkat cell stimulated on a coverslip substrate 
(see also Supplemental Movie S11). (C1) GFP–F-tractin-P at the IS before addition of CD-Jas. 
(C2) GFP–F-tractin-P at the IS in this same cell 4 min after addition of CD-Jas. (C3) Merged 
image between C2 (green) and farnesylated-RFP (red), which marks the plasma membrane. 
(C4) Kymograph of GFP–F-tractin-P in the region corresponding to the yellow line in C2. The 
positions of the LP/dSMAC and LM/pSMAC regions of the IS are indicated by the brackets 
above A3, A4, B4, and C5. The time scales (in seconds) for all of the kymographs shown are 
indicated on the right. Scale bars in A1, B1, and C1, 5 μm; in A3, A4, B3, and C4, 2 μm.
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we next transitioned to engaging cells on bilayers in order to test 
the effect of CD-Jas treatment on the inward movement of TCR 
MCs. As with coverslip-engaged cells, the addition of CD-Jas to bi-
layer-engaged cells expressing GFP–F-tractin-P and farnesylated 
mRFP caused the retraction of the actin network in the LP/dSMAC 
within 4 min (compare the signals for GFP–F-tractin-P before treat-
ment with CD-Jas [Figure 7, A1] to that 4 min after CD-Jas addition 
[Figure 7, A2]; see also Supplemental Movie S12). This inhibitory 
effect was rapid, as retraction of the actin network in the LP/dSMAC 
began within 1 min after addition of CD-Jas (compare the time of 
Jas addition [black arrowhead] to the time when the retraction of the 
LP/dSMAC began [orange arrowhead] in the kymograph in Figure 7, 
A4, which was taken from the region of the LP/dSMAC highlighted 
by the yellow line in A2). This inhibitory effect was also complete, as 
residual actin spikes were not observed after treatment (Figure 7, 
A2). In striking contrast to coverslip-engaged cells, however, in bi-
layer-engaged cells much of their leading-edge plasma membrane 
marked with farnesylated RFP retracted together with the actin net-
work in the LP/dSMAC (Figure 7, A3). This is presumably due to the 
lack of opposing friction in the planar bilayer substrate.
Despite the lack of complete separation between the retract-
ing actin network and the leading-edge plasma membrane, we 
proceeded to test the effect of CD-Jas treatment on the dynamics 
of both actin and TCR MCs within each region of the IS. In the LM/
pSMAC, the rate of actin arc contraction was reduced following 
the addition of CD-Jas by 37%, from 0.037 ± 0.003 to 0.023 ± 
0.002 μm/s (Figure 5A; compare LM/pSMAC WT actin to 
LM/pSMAC CD-Jas actin; p < 0.001). Moreover, the rate of inward 
TCR MC movement across the LM/pSMAC slowed by 44%, from 
0.039 ± 0.006 to 0.022 ± 0.002 μm/s (Figure 5A; compare LM/
pSMAC WT TCR to LM/pSMAC CD-Jas TCR; p < 0.001), matching 
the reduced rate of actin arc contraction in the LM/pSMAC. The 
directionality of TCR MC movements in the LM/pSMAC was not 
affected by Jas-CD treatment, however (Figure 5B; p > 0.05). We 
do note that a modest level of “pauses” in TCR MC movements 
was observed in the LM/pSMAC (Figure 5C). This pausing may be 
due to the large accumulation of F-actin at the boundary between 
the LM/pSMAC and cSMAC seen with Jas addition, which could 
create a logjam for TCR MCs passing into the cSMAC.
With regard to the LP/dSMAC following CD-Jas treatment, 
quantification showed that the rate at which the actin network in 
this zone retracted (0.023 ± 0.002 μm/s) corresponds exactly to the 
reduced speed of actomyosin II arc contraction in the LM/pSMAC 
(0.023 ± 0.002 μm/s; Figure 5; compare LP/dSMAC CD-Jas actin to 
LM/pSMAC CD-Jas actin: p > 0.05). This result is completely con-
sistent with previous results in Aplysia neuron growth cones and sea 
urchin coelomocytes, where actomyosin II contraction in the LM 
was shown to drive the retraction of the LP actin network following 
the addition of cytochalasin to inhibit actin polymerization at the 
leading edge (Henson et al., 1999; Medeiros et al., 2006). Most 
important, the speed at which TCR MCs move inward across the 
LP/dSMAC of CD-Jas treated cells (0.024 ± 0.002 μm/s) matches 
precisely the speed of actin network retraction (0.023 ± 0.002 μm/s; 
Figure 5A; compare LP/dSMAC CD-Jas TCR to LP/dSMAC CD-Jas 
actin and LM/pSMAC CD-Jas actin; p > 0.05). This result is also evi-
dent in the kymographs in Figure 7, B4–B6, which were taken from 
the region of the LP/dSMAC highlighted by the yellow line in B3. 
Specifically, the green arrowhead in B5 indicates that the TCR MC 
marked by the green arrowhead in B2 moved inward in concert with 
the retracting actin. These results indicate that TCR MCs are tightly 
coupled to the underlying cortical F-actin network during the re-
traction process. Moreover, these results argue that the contraction 
6 min (compare the signals for GFP–F-tractin-P before treatment with 
Jas [Figure 6, B1] to that 4 min [Figure 6, B2] and 6 min [Figure 6, B3] 
after addition of Jas; see also Supplemental Movie S10). Moreover, 
the actin arcs in the LM/pSMAC continued to contract inwardly, as 
evidenced by the slopes in the LM/pSMAC region of the kymograph 
in Figure 6, B4, which was taken from the region of the LM/pSMAC 
highlighted by the yellow line in B2. In addition, these arcs appeared 
to accumulate over time in the form of a dense ring of actin at the 
border between the LM/pSMAC and cSMAC (Figure 6, B2 and B3; 
see green arrowheads). The appearance of this actin ring presumably 
reflects the Jas-dependent inhibition in the disassembly of the acto-
myosin II arcs at the inner aspect of the LM (Medeiros et al., 2006; 
Wilson et al., 2010). We note that Jas addition caused the retracting 
actin network in the LP/dSMAC to also accumulate over time in the 
form of a broad actin ring at the border between LP/dSMAC and LM/
pSMAC (Figure 6, B2 and B3; see red arrowheads). The appearance 
of this ring presumably reflects the Jas-dependent inhibition in the 
large-scale depolymerization of LP F-actin that probably occurs at 
the inner aspect of the LP (Ponti et al., 2004).
Although treatment with 0.5 μM Jas was successful in that, 
given enough time, it resulted in the near-complete retraction of 
the LP actin network, that is, it did not leave behind the F-actin 
spikes observed with CD treatment, the time course of the effect 
was relatively slow. Specifically, whereas the accumulation of actin 
arcs near the cSMAC border was nearly complete after 4 min of Jas 
treatment (see the green arrowhead in Figure 6, B2), retraction of 
the actin network in the LP/dSMAC was just beginning at this point 
in time. This is evident in the kymograph in Figure 6, B4, where the 
time of Jas addition and the time when the retraction of the LP/
dSMAC began are marked by black and orange arrowheads, re-
spectively. This delay in the retraction of actin at the leading edge 
is presumably due to the fact that the mechanism by which Jas in-
hibits polymerization (monomer starvation) takes time to develop.
Given the foregoing results, we sought to block actin retrograde 
flow in the LP/dSMAC both rapidly and completely by simultane-
ously blocking both actin polymerization at the leading edge using 
0.2 μM CD and actin depolymerization at the rear of the LP using 0.5 
μM Jas (CD-Jas). In Jurkat cells expressing GFP–F-tractin-P and 
farnesylated-red fluorescent protein (RFP) and engaged on cover-
slips, addition of CD-Jas caused the entire actin network in the LP/
dSMAC to retract within 4 min (compare the signal for GFP–F-trac-
tin-P before treatment with CD-Jas [Figure 6, C1] to that 4 min after 
CD-Jas addition [Figure 6, C2]; see also Supplemental Movie S11). 
Moreover, this inhibitory effect was rapid, as the actin network in the 
LP/dSMAC began to retract within 1 min after addition of CD-Jas 
(compare the time of CD-Jas addition [black arrowhead] to the time 
when the retraction of the LP/dSMAC began [orange arrowhead] in 
the kymograph in Figure 6, C4, which was taken from the region of 
the LP/dSMAC highlighted by the yellow line in C2). Finally, the in-
hibitory effect of combined CD-Jas treatment was complete, as re-
sidual actin spikes were not observed (Figure 6, C2). Of importance, 
using farnesylated-RFP to mark the T cell plasma membrane, we 
confirmed that CD-Jas treatment caused the LP actin network to 
pull away from the leading-edge membrane (see the spatial separa-
tion between the signals for farnesylated-RFP and GFP–F-tractin-P 
in Figure 6, C3). Therefore the effect of combined CD-Jas treatment 
in Jurkat cells engaged on coverslips mirrors the classic result seen 
in giant Aplysia growth cones treated with cytochalasin B, where the 
actin meshwork in the LP separates and retreats from the leading-
edge plasma membrane (Forscher and Smith, 1988).
Having established a method to inhibit actin polymerization both 
rapidly and completely for cells engaged on a coverslip substrate, 
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of the actomyosin II arcs in the LM/pSMAC drives these slow inward 
movements of TCR MCs when actin polymerization is abrogated. 
Although the directionality of TCR MC movements in the LP/dS-
MAC were not affected by Jas-CD treatment (Figure 5B), a modest 
increase in “pauses” relative to control cells was observed (Figure 
5C). These pauses may be due to the accumulation of F-actin at the 
border between the LP/dSMAC and LM/pSMAC seen with Jas ad-
dition, which may create a logjam for TCR MCs passing into the 
pSMAC.
Finally, although most of the leading-edge plasma membrane of 
bilayer-engaged cells retracted together with the actin network fol-
lowing the addition of CD and Jas (Figure 7, A3), in a few instances 
portions of the plasma membrane remained in place as the actin 
network retreated (see white arrowheads in 
Figure 7, A3). In these cases, we observed 
small populations of marooned TCR MCs 
that were left behind by the retracting actin 
network in the LP/dSMAC (Figure 7, B2; see 
red arrowhead). These TCR MCs, which ap-
pear totally disengaged from the actin net-
work, were completely nonmotile, as evi-
denced by kymographs (Figure 7, B4–B6; 
see the red arrowhead). These observations 
are consistent with previous reports show-
ing that the centripetal transport of TCR 
MCs is completely blocked by the depo-
lymerization of F-actin by latrunculin (Varma 
et al., 2006; Kaizuka et al., 2007). Together 
the results are consistent with actin retro-
grade flow driving the fast (∼0.1 μm/s) move-
ment of TCR MCs in the LP/dSMAC and 
myosin II-dependent actin arc contraction 
driving the slow (∼0.03 μm/s) movement of 
TCR MCs in the LM/pSMAC.
Simultaneous inhibition of both actin 
retrograde flow and actomyosin II arc 
contraction blocks the vast majority 
of centripetal TCR MC movements at 
the IS
To confirm that TCR MC movements at the 
IS are driven largely if not entirely by a com-
bination of two forces—the pushing force of 
actin polymerization-driven retrograde flow 
and the pulling force of myosin II-driven actin 
arc contraction—we sought to inhibit both of 
these forces simultaneously using combined 
treatment with 50 μM BB, 0.2 μM CD, and 
0.5 μM Jas (BB-CD-Jas). Using bilayer-en-
gaged Jurkat cells expressing tdTomato–F-
tractin-P that had been preincubated with 
BB for 30 min, we found that addition of CD 
and Jas in the continued presence of BB re-
sulted in the nearly immediate and complete 
inhibition of actin retrograde flow and actin 
arc contraction. This overall freezing of F-ac-
tin movement throughout the cell is evident 
in the kymograph of tdTomato–F-tractin-P in 
Figure 7, C3, which was taken from the re-
gion of the IS highlighted by the yellow line 
across the cell in Figure 7, C1 (Tomato–F-
tractin-P in a BB-pretreated cell before addi-
tion of BB-CD-Jas) and Figure 7, C2 (Tomato–F-tractin-P in this same 
BB-pretreated cell 30 s after addition of BB-CD-Jas; the time of addi-
tion of BB-CD-Jas is marked by the black arrowhead in C3; see also 
Supplemental Movie S13). Indeed, the rate of retrograde actin flow 
across the LP/dSMAC in these cells was reduced by 97%, from 
0.105 ± 0.006 to 0.003 ± 0.002 μm/s; Figure 5A; compare LP/dSMAC 
WT actin to LP/dSMAC BB-CD-Jas actin; p < 0.001). Similarly, the 
rate of actin arc contraction across the LM/pSMAC in these cells was 
reduced by 93%, from 0.037 ± 0.003 to 0.003 ± 0.001 μm/s (Figure 
5A; compare LM/pSMAC WT actin to LM/pSMAC BB-CD-Jas actin; 
p < 0.001). Of note, these effects on actin flow were reversible, as ac-
tin polymerization and retrograde flow resumed almost immediately 
when the three drugs were washed out 5 min after their addition 
FIGURE 7: Inhibition of actin retrograde flow and actomyosin II arc contraction using 
combinations of CD, Jas, and BB. (A) Effect of CD-Jas treatment on the dynamics and 
distribution of F-actin at the IS of a Jurkat cell stimulated on a planar bilayer (see also 
Supplemental Movie S12). (A1) GFP–F-tractin-P at the IS of a cell before addition of CD-Jas. 
(A2) GFP–F-tractin at the IS of this same cell 4 min after addition of CD-Jas. (A3) Merged image 
between A2 (green) and farnesylated-RFP (red), which marks the plasma membrane. (A4) 
Kymograph of the region corresponding to the yellow line in A1 and A2. The black arrowhead 
indicates the time of CD-Jas addition, and the blue arrowhead indicates the start of actin 
retraction in the LP/dSMAC. (B) Effect of CD-Jas treatment on F-actin dynamics and distribution 
and on TCR MC movement at the IS of a Jurkat cell stimulated on a planar bilayer. (B1) GFP–F-
tractin-P at the IS of a cell 4 min after addition of CD-Jas. (B2) TCR MCs at the IS of this same 
cell 4 min after addition of CD-Jas. The red arrowhead marks the position of a marooned TCR 
MC. The green arrowhead marks a TCR MC that moved with the retracting actin network. (B3) 
Merged image between B1 (red) and B2 (green). (B4) Kymograph of GFP–F-tractin-P in the 
region corresponding to the yellow line in B3, (B5) kymograph of TCR MCs in the region 
corresponding to the yellow line in B3, and (B6) merged image between B4 (red) and B5 (green). 
The red arrowhead in B5 indicates the immobile, marooned TCR MC marked in B2 that was left 
behind at the IS periphery, whereas the green arrowhead in B5 indicates the TCR MC marked in 
B2 that moved with the retracting actin network (see B6 for the overlay). (C) The effect of 
combined CD-Jas-BB treatment on F-actin dynamics and distribution at the IS of a Jurkat cell 
stimulated on a planar bilayer (see also Supplemental Movie S13). (C1) tdTomato–F-tractin-P at 
the IS of a BB-pretreated cell before addition of CD-Jas-BB. (C2) tdTomato–F-tractin-P at the IS 
of this same cell 30 s after addition of CD-Jas-BB. (C3) Kymograph of the region corresponding 
to the yellow line in C1 and C2. The black arrowhead in C3 indicates the time of CD-Jas-BB 
addition. The positions of the LP/dSMAC and LM/pSMAC regions of the IS are indicated by the 
brackets above A4 and C3. The time scales of the kymographs in A3, B4–B6, and C3 are 
indicated to the right of A4, B6, and C3, respectively. Scale bars in A1, B1, and C1, 5 μm; scale 
bars in A4, B3, and C3, 2 μm.
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(data not shown). Most important, consistent with our two-force 
model for the inward movement of TCR MCs, TCR MC movement 
across the LP/dSMAC was reduced in BB-CD-Jas–treated cells by 
97%, from 0.094 ± 0.016 to 0.003 ± 0.002 μm/s; Figure 5A; compare 
LP/dSMAC WT TCR to LP/dSMAC BB-CD-Jas TCR; p < 0.001), 
whereas the inward movement of TCR MCs across the LM/pSMAC 
was reduced by 94%, from 0.038 ± 0.006 to 0.002 ± 0.001 μm/s; 
Figure 5A; compare LM/pSMAC WT TCR to LM/pSMAC BB-CD-Jas 
TCR; p < 0.001). Taken together, these results argue that actin retro-
grade flow and actomyosin II arc contraction cooperate to drive the 
vast majority of centripetal TCR MC transport at the IS.
Actomyosin II contraction is required for the accumulation 
of LFA-1 clusters at the inner aspect of the LM/pSMAC
Finally, we investigated the relationship between the F-actin net-
work and the distribution of LFA-1 clusters at the IS by characteriz-
ing in greater detail the apparent spatial overlap (Figure 1, B1–B6 
and E1–E6) between these clusters and the actomyosin II arcs that 
populate the LM/pSMAC. To report the localization of ligand-bound 
LFA-1 clusters in the plasma membrane, Jurkat cells were engaged 
on planar bilayers containing ICAM-1 tagged with Alexa 546. One 
min after bilayer engagement, LFA-1 clusters were distributed largely 
evenly across the LM/pSMAC (Figure 8, A1, and the corresponding 
line scan in A2). Separate control experiments performed using Jur-
kat cells expressing the HC of myosin IIA tagged with GFP confirmed 
that this distribution of LFA-1 clusters largely overlaps that of the 
actomyosin II arcs in the LM/pSMAC (data 
not shown). After 3 min, however, LFA-1 
clusters had begun to accumulate near the 
border between the LM/pSMAC and cS-
MAC, leading to the formation of a gradient 
of LFA-1 clusters across the LM/pSMAC 
(Figure 8, A3). This gradient is evident in line 
scans across the IS, which show a progres-
sive increase in the fluorescence intensity of 
ICAM-1 as one approaches the pSMAC/cS-
MAC border (Figure 8, A4). Moreover, after 
5 min (Figure 8, A5), the peak intensity of 
ICAM-1 signal at the inner aspect of the LM/
pSMAC, defined as the innermost 1-μm-
wide region of the LM/pSMAC, was approxi-
mately threefold higher than the peak inten-
sity of ICAM-1 in this same region after only 
1 min of engagement (compare the ICAM-1 
signal at the inner aspect of the LM/pSMAC 
in Figure 8, A2 [1 min; red arrowheads] with 
that in Figure 8, A6 [5 min; green arrow-
heads]; see also Supplemental Movie S14, 
left). This is, to our knowledge, the first de-
scription of LFA-1 cluster accumulation at 
the inner aspect of the LM/pSMAC, and it 
may represent a distinct maturation step in 
the formation of the adhesion zone between 
the T cell and the APC.
Finally, we used BB to test the role of ac-
tomyosin II arc contraction in driving the two 
distinct phases of LFA-1 cluster localization at 
the IS, that is, evenly distributed LFA-1 clus-
ters in the LM/pSMAC after 1 min, and ac-
cumulation of LFA-1 clusters at the inner as-
pect of the LM/pSMAC after 5 min. In 
bilayer-engaged, BB-treated cells, LFA-1 
clusters appeared evenly distributed across the LM/pSMAC after 1 
min of engagement, similar to WT and DMSO-treated cells (Figure 8, 
B1, C1, and D1). This result indicates that the early phase of LFA-1 
cluster distribution across the LM/pSMAC is independent of myosin 
II contraction. In contrast, whereas LFA-1 clusters accumulated at the 
inner aspect of the LM/pSMAC after 5 min in WT and DMSO-treated 
cells (Figure 8, B2 and C2), they did not accumulate at this region in 
BB-treated cells (Figure 8, D2; see also Supplemental Movie S14, 
right). Quantitation of the increase in intensity of ICAM-1 signals 
within a 1-μm-square area at the inner aspect of the pSMAC (boxed 
regions in Figure 8, B1, B2, C1, C2, D1, and D2) showed that the av-
erage total intensity of ICAM-1 in this region increased from 1 min of 
engagement to 5 min of engagement by 41 ± 20% in WT cells and by 
42 ± 8% in DMSO-treated cells but by only 2 ± 9% in BB-treated cells 
(Figure 8E). Indeed, LFA-1 clusters appeared evenly distributed across 
the LM/pSMAC of BB-treated cells even after 10 min of engagement 
(data not shown). We conclude, therefore, that whereas myosin II ac-
tivity is not required for the early phase of LFA-1 cluster distribution in 
the LM/pSMAC, it does play an important role in the subsequent ac-
cumulation of these clusters at the inner aspect of the LM/pSMAC.
DISCUSSION
Previous studies established that the dSMAC region of the IS cor-
responds to an actin network characterized by robust actin polymer-
ization–driven retrograde flow, that is, to a LP. Using F-tractin-P, a 
novel reporter for F-actin, we defined for the first time in a clear way 
FIGURE 8: The effect of myosin II inhibition on the accumulation of LFA-1 clusters at the inner 
aspect of the LM/pSMAC. (A) Accumulation of LFA-1 clusters at the inner aspect of the LM/
pSMAC in Jurkat cells stimulated on planar bilayers (see also Supplemental Movie S14). (A1) 
Distribution of LFA-1clusters, reported by Alexa 546–labeled ICAM-1 in the bilayer, at the IS of a 
Jurkat cell 1 min after engagement on a planar bilayer. (A3) LFA-1 clusters in the same cell 3 min 
after engagement. (A5) LFA-1 clusters in the same cell 5 min after engagement. (A2, A4, A6) 
Relative intensities of ICAM-1 fluorescence in the line scans (yellow lines) in A1, A3, and A5, 
respectively. Arrowheads indicate peaks of ICAM-1 fluorescence intensity in A2 (red) and A6 
(green). (B–D) Distributions of LFA-1 clusters at the IS of WT and DMSO- and BB-treated Jurkat 
cells stimulated on planar bilayers. (B) LFA-1 clusters at the IS of a WT Jurkat cell 1 min (B1) and 
5 min (B2) after engagement. (C) LFA-1 clusters at the IS of a DMSO-treated Jurkat cell 1 min 
(C1) and 5 min (C2) after engagement. (D) LFA-1 clusters at the IS of a BB-treated Jurkat cell 
1 min (D1) and 5 min (D2) after engagement. (E) Percentage increase in the accumulation of 
ICAM-1 fluorescence at the inner aspect of the pSMAC (i.e., within the yellow boxed regions in 
B1–D2) 5 min after bilayer engagement in WT and DMSO- and BB-treated cells. The numbers of 
cells used per measurement are indicated inside (or above) the bar. Scale bar in A5, 5 μm; in B2, 
C2, and D2, 2 μm.
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the organization of F-actin in the pSMAC region of the IS. Of impor-
tance, the actin arcs that populate the pSMAC are endogenous 
structures, and they undergo myosin II-driven contraction that drives 
their inward movement. These and other observations clearly define 
the pSMAC as a LM actin network, as hypothesized by Dustin (2007). 
Moreover, as in typical crawling cells, we found that the dynamics of 
F-actin in the LP/dSMAC and LM/pSMAC are both distinct and in-
terdependent. Specifically, the fast (∼0.1 μm/s) pushing force of ret-
rograde actin flow in the LP/dSMAC depends in part on the slower 
(∼0.03 μm/s) pulling force provided by the contracting actomyosin II 
arcs in the LM/pSMAC and vice versa. Most important, we showed 
that the speeds with which TCR MCs move from the perimeter of 
the cell inward to the cSMAC follow very closely the speeds of actin 
flow in the LP/dSMAC and LM/pSMAC regions of the IS. Moreover, 
inhibition of actin flow in these latter two zones individually and in 
combination showed that the flow of actin in these two zones drives 
most if not all inward TCR MC movement. Finally, we showed that 
the normal accumulation of integrin clusters at the inner aspect of 
the LM/pSMAC requires myosin II–driven actin arc contraction.
Correspondence between LP and LM actin networks 
and the SMAC regions of the IS
Our demonstration that the dSMAC, pSMAC, and cSMAC coincide 
spatially with the LP, LM, and actin-depleted central zone in bilayer-
engaged cells provides strong support for the model proposed by 
Dustin (2007). Moreover, our observations indicate that the actin cy-
toskeleton at the IS conforms to the classic model of spatially distinct, 
nonoverlapping LP and LM actin networks at the leading edge of 
cells (Henson et al., 1999; Zhang et al., 2003; Medeiros et al., 2006), 
as opposed to the two-layered model of Sheetz and colleagues 
(Giannone et al., 2007), in which the LP actin network is proposed to 
overlap with and exist on top of the LM network. Specifically, both 
endogenous staining and dynamic imaging of actin and myosin II 
show that the LP and LM actin networks at the Jurkat IS are com-
pletely distinct spatially. Moreover, kinetic data show that the inward 
movement of TCR MCs in the LP/dSMAC corresponds to the rate of 
actin retrograde flow and not to a mixture of rates corresponding to 
actin retrograde flow and actomyosin II contraction, as would be ex-
pected from a two-layered organization of actin in the LP/dSMAC.
Our results using coverslip substrates coated with immobilized 
anti-CD3ε antibodies also show that the LP and LM actin networks 
form independently of receptor cluster reorganization at the IS 
membrane. These and other observations argue strongly that the 
formation of LP and LM networks is upstream of SMAC formation 
and that, once established, actin dynamics in these two networks 
drive the reorganization of receptors into the concentric SMAC do-
mains. Indeed, the normal accumulation of LFA-1 clusters near the 
pSMAC-cSMAC border signifies that the pSMAC is but a snapshot 
of receptors at the dynamically changing IS membrane, whose dis-
tribution is driven by a distinct cortical LM network containing con-
tracting actomyosin II arcs.
Novel observation of contracting actomyosin II arcs 
in the LM/pSMAC
We imaged for the first time actomyosin II arcs in the LM/pSMAC 
region of the IS. These arcs were observed as both endogenous 
structures and as dynamic structures using tdTomato–F-tractin-P to-
gether with GFP-tagged myosin II constructs. Previous imaging of 
endogenous F-actin at the IS was not of sufficient resolution to iden-
tify specific actin structures within the LM/pSMAC (Sims et al., 2007). 
Even more important, essentially all previous efforts to image F-ac-
tin dynamics at the IS used GFP-actin (Bunnell et al., 2001; Kaizuka 
et al., 2007; Yu et al., 2010), which we show here localizes very 
poorly to these actin arcs. Not surprisingly, therefore, the existence 
of these actin arcs in the LM/pSMAC was not reported in any previ-
ous live-imaging study. That said, close inspection of previously 
published movies made using GFP-actin (see, e.g., SI Supplemental 
Movie S2 in Kaizuka et al., 2007) hint at the endogenous actin arcs 
described here. Moreover, Yu et al. (2010) reported that the speed 
with which GFP-actin speckles move inward slows as the speckles 
move further from the cell perimeter, consistent with our observa-
tions that actin flow is fast in the LP/dSMAC and slow in the LM. The 
key advantage here was our use of F-tractin (Johnson and Schell, 
2009), which we believe is clearly superior to GFP-actin for imaging 
actin structures/dynamics in Jurkat T cells. Why GFP-actin does not 
incorporate efficiently into actin arcs is unclear but may have to do 
with the likelihood that formins, which may play an important role in 
forming the arcs (Tojkander et al., 2011), do not use GFP-actin effi-
ciently (if at all) as a substrate (Wu et al., 2006). Finally, consistent 
with numerous studies demonstrating that myosin II contraction is 
the major driving force behind cortical actin flow in the LM (Lin et al., 
1996; Henson et al., 1999; Ponti et al., 2004; Medeiros et al., 2006), 
we provided multiple lines of evidence that the actomyosin II arcs 
reported here are undergoing myosin II–driven contraction. Most 
important, discontinuities in GFP–myosin II fluorescence within arcs 
get closer together with time, consistent with arc contraction, and 
BB treatment results in flaccid arcs that move inward in a slow and 
haphazard manner due solely to the continued pushing force of ac-
tin retrograde flow in the LP.
Kinetic coupling between TCR MC movement and cortical 
actin network flow at the IS
We observed a very strong correspondence between the rates of 
centripetal actin flow and inward TCR MC movement across both the 
LP/dSMAC and LM/pSMAC regions of the IS. Moreover, this strong 
kinetic coupling between cortical actin flow and inward TCR MC 
movement was maintained after each drug treatment. This strong 
coupling is in contrast to a previous report using bilayer-engaged 
Jurkat T cells (Kaizuka et al., 2007), in which the rate of inward TCR 
MC movement at the periphery of the IS was reported to be ∼40% 
the rate of centripetal actin flow. As described in more detail in the 
Introduction, this and other studies—especially those that have char-
acterized the effects of physical barriers within the bilayer on the 
rates of TCR MC movement (Hartman and Groves, 2011)—have led 
to a dissipative or frictional coupling model of TCR MC–actin cy-
toskeleton interaction that allows slippage between the MC and ac-
tin flow. Although we certainly believe that such slippage would oc-
cur if we had used physical barriers, we think that in the absence of 
such barriers the coupling between TCR MCs and actin flow is prob-
ably quite tight. That said, at least part of the difference between our 
study and that of Kaizuka and colleagues as regards the kinetic cou-
pling between actin flow and TCR MC movement could be due to 
possible differences in bilayer conditions between the two studies 
(e.g., densities of ICAM-1 and anti-CD3ε antibody, lipid mobility). It 
is also possible that, in the study by Kaizuka et al. (2007), the quanti-
tation of actin flow rate was restricted largely to the LP/dSMAC (due 
to the use of GFP-tagged actin), whereas the quantitation of TCR 
MC movements was made predominately in the LM/pSMAC, lead-
ing to the discrepancy between their respective centripetal rates. 
Obviously, much remains to be learned regarding the components 
and physical properties of the mechanisms that couple TCR MCs 
and integrin clusters to cortical actin flow during IS formation.
Our demonstration that TCR MCs exhibit two distinct rates of 
centripetal movement across the IS can actually be reconciled with a 
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large number of rates reported previously. First, the fast rate 
(∼0.1 μm/s) across the LP/dSMAC reported here corresponds rela-
tively well with rates at the periphery of the IS reported by several 
groups (∼0.09 μm/s, Yokosuka et al., 2005; ∼0.14 μm/s, Kaizuka 
et al., 2007; ∼0.15 μm/s, Ilani et al., 2009). Moreover, the slow rate 
(∼0.03 μm/s) across the LM/pSMAC reported here corresponds quite 
well with rates reported for regions of the IS that are almost certainly 
inside the LP/dSMAC, that is, to the LM/pSMAC (∼0.04 μm/s, 
Yokosuka et al., 2005; ∼0.03 μm/s, Varma et al., 2006; ∼0.02 μm/s, 
DeMond et al., 2008). Thus our finding that TCR MCs move at differ-
ent speeds depending on the region of movement, that is, the LP/
dSMAC versus the LM/pSMAC, helps to reconcile the wide range of 
speeds reported previously for TCR MC movements at the IS.
The role of myosin IIA at the IS
As discussed in the Introduction, the role of myosin IIA in IS forma-
tion has been somewhat controversial. Specifically, an earlier study 
using BB argued that myosin IIA is not required for IS formation 
(Jacobelli et al., 2004), whereas a more recent report using BB and 
RNAi-mediated knockdown of myosin II argued that the myosin is 
required for significant TCR MC transport, cSMAC formation, and IS 
stability (Ilani et al., 2009). Our study offers a possible bridge be-
tween these divergent reports, in that myosin II was found to play an 
important but not essential role in IS formation. Specifically, our data 
show that actin retrograde flow and actomyosin II–based flow coor-
dinately drive receptor cluster movements at the IS. Moreover, in the 
absence of myosin IIA activity, the pushing force of actin retrograde 
flow in the LP/dSMAC can drive residual cortical actin flow and TCR 
MC movement across the LM/pSMAC, albeit slowly and with greatly 
reduced directional persistence. Thus, although the quality and 
speed of TCR MC movements across the LM/pSMAC are dramati-
cally disrupted in BB-treated cells, the overall bull’s-eye–patterned IS 
can still form over time in a significant fraction of myosin II–inhibited 
T cells. Finally, our demonstration of the dramatic effect that BB has 
on the organization and dynamics of the actin arcs that populate the 
LM/pSMAC, as well as the distortion and slow inward displacement 
of these disorganized, flaccid arcs that occurs as a result of contin-
ued actin retrograde flow in the LP/dSMAC of BB-treated cells, pro-
vides a mechanistic framework in which to understand the effects of 
myosin II inhibition on the motion of TCR MCs during IS formation.
Regulation and dynamics of F-actin networks at the IS
Our functional inhibition experiments revealed several important as-
pects of actin network regulation at the IS. For example, inhibition of 
actomyosin II arc contraction slowed actin retrograde flow in the 
LP/dSMAC, whereas inhibition of actin retrograde flow slowed ac-
tomyosin II arc contraction in the LM/pSMAC. Such interdepen-
dence between pushing and pulling forces in the LP/dSMAC and 
LM/pSMAC, respectively, have been observed in the LP and LM of 
numerous cell types (Lin et al., 1996; Henson et al., 1999; Ponti et al., 
2004), arguing for a conserved mechanism of cortical F-actin regula-
tion in T cells. Also of note, the appearance of two prominent F-actin 
rings following the addition of Jas suggests that robust actin depo-
lymerization is occurring at the borders between the LP/dSMAC-
LM/pSMAC and the LM/pSMAC-cSMAC. This conclusion is consis-
tent with studies in other cell types showing that ∼90% of LP F-actin 
depolymerizes at the rear of the LP (Ponti et al., 2004) and that myo-
sin II–dependent contraction leads to actin bundle disassembly at 
the rear of the LM (Medeiros et al., 2006; Wilson et al., 2010). Finally, 
we note that the rate of actin retrograde flow at the IS (∼0.10 μm/s) 
is much faster than in other model cell systems (e.g., ∼0.01 μm/s in 
PTK1 cells, Ponti et al., 2004; and ∼0.06 μm/s in neuronal growth 
cones, Medeiros et al., 2006). This fact, together with the clear pres-
ence of organized, dynamic actin arcs in the LM/pSMAC, suggests 
that Jurkat T cells, which are easily transfected and amenable to 
RNAi knockdown, could serve as a robust model system for studying 
the regulation and dynamics of the actin cytoskeleton, similar to 
what has been done using Drosophila S2 cells (Rogers et al., 2003).
Role of microtubules and dynein-based TCR MC transport 
at the IS
Recently Saito and colleagues reported that, whereas actin retro-
grade flow drives the inward movement of TCR MCs at the periphery 
of the IS (approximately the LP/dSMAC), the minus end–directed 
microtubule motor dynein drives the inward movement of TCR MCs 
along microtubules at the inner regions of the IS (approximately the 
LM/pSMAC and cSMAC; Hashimoto-Tane et al., 2011). Furthermore, 
complementary work by the Batista lab showed that dynein associ-
ates with the B cell receptor (BCR) and that dynein likewise drives the 
centripetal movement of BCR MCs at the B cell synapse (Schnyder 
et al., 2011). These observations are a distinct departure from the 
widely held view that the inward flow of cortical F-actin drives the 
centripetal transport of TCR MCs (Babich and Burkhardt, 2011). In-
deed, like previous data using latrunculin to disassemble the actin 
cytoskeleton (Varma et al., 2006; Kaizuka et al., 2007), our data using 
combined treatment with CD, Jas, and BB to freeze the actin cy-
toskeleton argues that most if not all inward TCR MC movement is 
driven by the cortical flow of F-actin. How to reconcile these studies, 
and how microtubule-dependent TCR MC transport might be coor-
dinated with actin-based transport, particularly in the LM/pSMAC 
region of the IS, are unclear. For example, given that the inhibition of 
dynein or microtubule assembly inhibited only those extremely rapid 
(>0.4 μm/s) TCR MC movements that occur during the first 30 s of 
TCR MC movement (Hashimoto-Tane et al., 2011), we might have 
missed many of them. Alternatively, the centripetal movement of 
TCR MCs in the actin-depleted cSMAC region might be largely dy-
nein driven, whereas TCR MC movement in the dSMAC and pSMAC 
might be driven largely by actin retrograde flow and actomyosin II 
arc contraction, respectively. The possibility also exists that dynein-
dependent MC movements only occur in the presence of an intact, 
functioning actin cytoskeleton, although we never witnessed the 
very rapid movements of MCs described by Saito and colleagues, 
even in untreated cells. More experiments are needed to resolve 
these complex issues.
Conclusion
Overall, our study provides an integrated model of actin-based re-
ceptor cluster transport at the IS. Specifically, our results show that 
coordination between the pushing force of actin retrograde flow in 
the LP/dSMAC and the pulling force of actomyosin II arc contraction 
in the LM/pSMAC drives the centripetal transport of TCR MCs at the 
IS. Thus, as predicted by Dustin (2007) and confirmed here, the actin 
cytoskeleton at the IS represents a symmetric version of a migrating 
cell, where retrograde forces within LP and LM actin networks that 
serve to move the cell forward are converted into centripetal forces 
at the IS to move receptor complexes toward the center of the IS. 
This conservation in cytoskeletal mechanism may be further re-
flected in our observation that the accumulation of LFA-1 clusters at 
the inner LM/pSMAC requires actomyosin II arc contraction, as the 
contractile force of myosin II links integrin receptors to the extracel-
lular matrix within the LM of migrating cells (Pasapera et al., 2010). 
Indeed, we believe that LFA-1 receptor clusters are probably inti-
mately linked to the actomyosin II arcs identified here within the 
LM/pSMAC, the region where myosin II–driven receptor transport 
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and substrate adhesion are integrated at the IS. The details of these 
interactions, which occur within the region of active TCR signaling 
and tightest apposition between the T cell and APC, represent im-
portant areas for further investigation.
MATERIALS AND METHODS
Cell culture and transfection
E6.1 Jurkat T cells (a gift from L. Samelson, National Cancer Insti-
tute, National Institutes of Health, Bethesda, MD), which were used 
for all experiments, were maintained at 37°C in IMDM media 
(12440; Invitrogen, Carlsbad, CA) supplemented with fetal bovine 
serum (F0392; Sigma-Aldrich, St. Louis, MO), sodium pyruvate 
(11360; Invitrogen), l-glutamine (25030; Invitrogen), penicillin–
streptomycin (15140; Invitrogen), and MEM nonessential amino 
acids solution (11140; Invitrogen). Cells were replated every 48 h at 
a concentration of 2.0 × 105 cells/ml. Transfections were performed 
by nucleofection using cells at a concentration of 1.0 × 106 cells/ml, 
1–3 μg of plasmid DNA, Amaxa Kit V (Lonza, Basel, Switzerland), 
and the electroporation protocol for Jurkat T cells.
Plasmids and reagents
F-Tractin-P (ITPKA-9-52) tagged with mGFP or tdTomato were gifts 
from M. Schell. The mouse myosin IIA heavy chain and mouse myo-
sin II regulatory light chain constructs tagged with mGFP and mRFP, 
respectively, as well as the polyclonal antibody against human plate-
let myosin IIA heavy chain, were gifts from R. S. Adelstein (National 
Heart, Lung, and Blood Institute, National Institutes of Health, 
Bethesda, MD). The anti–p34-arc antibody was purchased from 
Upstate Cell Signaling Solutions (07-227; Millipore, Billerica, MA). 
Alexa 568–conjugated phalloidin, Alexa 488 and Alexa 568–conju-
gated goat anti-rabbit secondary antibodies, jasplakinolide (J7473), 
and Fluo-4 AM (F14217) were purchased from Molecular Probes (In-
vitrogen). Cytochalasin D (250255) was purchased from Calbiochem 
(La Jolla, CA). Blebbistatin (B592500) was purchased from Toronto 
Research Chemicals (North York, Canada). DMSO (472301) used to 
reconstitute inhibitors and as a vehicle control was purchased from 
Sigma-Aldrich.
Fixation and staining
Jurkat cells were allowed to adhere to the substrate for 5 min at 
37°C and then fixed for 15 min in a solution containing 4% (wt/vol) 
paraformaldehyde (00380; Polysciences, Warrington, PA) and 1× 
phosphate-buffered saline (PBS), pH 7.4 (119-069-101; Quality Bio-
logical, Gaithersburg, MD). Samples were then incubated in a block-
ing solution consisting of 10% fetal bovine serum (F0392; Sigma-
Aldrich), 0.01% sodium azide (S8032; Sigma-Aldrich), 1× PBS, and 
0.2% saponin (S-7900; Sigma-Aldrich) for 15 min at room tempera-
ture (RT). Following three 5-min washes in 1× PBS, the cells were 
stained with primary antibody (1:200- to 500-fold dilution in 1× PBS) 
for 60 min at RT, followed by secondary antibody (1:1000-fold dilu-
tion in 1× PBS) or phalloidin (1:200-fold dilution) for 60 min at RT. 
Following three 5-min washes in PBS, the cells were stored in PBS 
and imaged immediately.
Planar lipid bilayers and immobilized coverslip substrates
Liposomes were prepared and glass-supported planar lipid bilayers 
were formed essentially as described previously (Dustin, 2007). Li-
posomes were created using a mixture of 1,2-dioleoyl-sn-glycero-3-
phosphocholine (850375C; Avanti Polar Lipids, Alabaster, AL), bio-
tin-CAP-PE (1% molar ratio; 180061C; Avanti Polar Lipids), and 
1,2-dioleoyl-sn-glycero-3-[(N-(5-amino-1-carboxypentyl)iminodia-
cetic acid)succinyl] (DGS)–NTA (1% molar ratio; 790528C; Avanti 
Polar Lipids) lipids. The anti-CD3ε antibody (OKT3; BioVest Interna-
tional, Tampa, FL) was monobiotinylated and labeled with fluores-
cent dyes following the protocol of Carrasco et al. (2004). A flow 
chamber was assembled by initially attaching two layers of double-
sided tape to the sides of a glass slide. To create a bilayer within the 
flow cell, a 1.5-μl drop of liposomes was deposited on the glass slide 
between the strips of double-stick tape, and then a glass coverslip 
that had been washed in Piranha solution (70% [vol/vol] sulfuric acid 
[A300; Fisher Scientific, Waltham, MA] and 30% [vol/vol] hydrogen 
peroxide [H325; Fisher Scientific]) was placed on top of the glass 
slide across the double-stick tape, simultaneously allowing a single 
planar bilayer to form on the coverslip surface and creating a flow 
chamber. Then 200 μl of 4-(2-hydroxyethyl)-1-piperazineethanesul-
fonic acid buffer saline was flowed through the chamber to wash 
away remaining liposomes, followed by 100 μl of a blocking solution 
containing 5% (wt/vol) casein (C5890; Sigma-Aldrich) to block non-
specific sites. Next, a 1:2 ratio of monobiotinylated anti-CD3ε anti-
body labeled with either Alexa 647 or rhodamine-X (10 μg/ml) and 
streptavidin (85878; Sigma-Aldrich) was added to the flow chamber 
to conjugate the anti-CD3ε antibody with the biotin-CAP-PE lipids in 
the bilayer. Similarly, histidine (His)-tagged ICAM-1, either unlabeled 
or labeled with Alexa 647 (0.5 μg/ml), was added to the flow cham-
ber to conjugate with the DOGS-NTA lipids in the bilayer. The uni-
formity and lateral mobility of lipids in the bilayers was accessed by 
imaging the diffusion of His-tagged ICAM-1 molecules labeled with 
Alexa 647 on the surface of the bilayer. Coverslip substrates coated 
with immobilized antibodies were prepared following the protocol 
of Bunnell et al. (2003). Specifically, eight-well cover-glass chamber 
slides (155411; Lab-Tek, Nalge Nunc International, Rochester, NY) 
were washed in a cleaning solution consisting of 1 M hydrogen chlo-
ride (H613; Mallinckrodt, St. Louis. MO) and 70% (vol/vol) ethanol 
(64-175; Warner-Graham, Cockeysville, MD) diluted in double-dis-
tilled H2O. Following three 5-min washes in 1× PBS, each well was 
then incubated for 30 min at RT in 500 μl of a solution containing 
0.01% poly-l-lysine (P8920; Sigma-Aldrich,). After a washing step, 
each well was then incubated for 30 min at RT in 500 μl of a solution 
containing 20 μg/μl of anti-CD3ε antibody and 20 μg/μl of anti-
CD28 antibody (555725; BD PharMingen, San Diego, CA) diluted in 
1× PBS. Wells were used following a washing step.
Image acquisition
Images were acquired using either a 100× (1.40 numerical aperture 
[NA]) or 150× (1.45 NA) objective on an Olympus (Tokyo, Japan) IX81 
microscope fitted with a Yokogawa (Tokyo, Japan) CSU-X1 spinning 
disk confocal unit and a QuantEM 512SC camera (Photometrics, 
Tucson, AZ). Images were analyzed using MetaMorph software 
(Molecular Devices, Sunnyvale, CA). For dynamic imaging, we loaded 
cells into a flow chamber containing the planar bilayer, placed the 
chamber on the microscope stage, identified cells that were well en-
gaged and spread, and then began imaging immediately. In general 
this process took 2 min. All time-lapse images were acquired at 
4 s/frame over 5 min, unless indicated otherwise. For simultaneous 
imaging of fluorescent molecules in the bilayer and in the cortex of 
the Jurkat cell, imaging was performed at the plane of the bilayer. For 
the z-stack imaging of endogenous F-actin structures at the IS, a Prior 
NanoScanZ stage controller system (Prior Scientific, Rockland, MA) 
was used to acquire 2-μm-thick z-sections of phalloidin-stained Jurkat 
cells engaged on bilayers. Line scans (through the zx-axis) across the 
LP/dSMAC and LM/pSMAC were obtained from the acquired z-stack 
images using MetaMorph software. For dynamic imaging, the 
temperature of the stage was maintained at 37°C using a Nevtek 
(Williamsville VA) stage heater. For imaging of calcium fluxes, Jurkat 
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cells were loaded with Fluo-4 AM as described in the Molecular 
Probes product information sheet and stimulated using coverslip 
substrates. The Prior NanoScanZ stage controller was used to take 
four-dimensional time-lapse images of these cells before and after 
contact with stimulatory coverslip substrates. The relative intensities 
of Fluo-4 fluorescence over time were calculated using the region 
measurement tool in MetaMorph software. For inhibitor studies us-
ing CD and/or Jas, mGFP–F-tractin-P–expressing cells were imaged 
for 2 min after engagement with the substrate. When eight-well cov-
erslip chambers were used, 0.2 μM CD and/or 0.5 μM Jas were 
added directly without removal of the chamber from the stage, allow-
ing continuous imaging of the cells. When planar bilayer substrates 
were used, the flow chamber was removed from the microscope 
stage, and 0.2 μM CD and/or 0.5 μM Jas was rapidly flowed into the 
chamber. The chamber was then returned to the previous xy-position 
on the stage to allow imaging of the same cells. These procedures 
took ∼30 s to complete. For BB studies using bilayer-engaged T cells, 
50 μM BB was added to the flow chambers as just described. For 
these experiments, we did not use the 488-nm laser line, as blue light 
rapidly inactivates BB, and the inactivation reaction generates harm-
ful free radicals (Allingham et al., 2005). Moreover, to ensure the ef-
ficacy of BB, we reconstituted it in the dark, froze it in aliquots at 
10 μl, and used only freshly thawed aliquots once. Jurkat cells were 
preincubated for 30 min in 50 μM BB before imaging. In experiments 
using BB, CD, and Jas, tdTomato–F-tractin-P–expressing Jurkat cells 
were incubated for 30 min in 50 μM BB, added to the planar bilayer 
flow chamber, and imaged for 2 min on the microscope. The cham-
ber was then removed, 50 μM BB, 0.2 μM CD, and 0.5 μM Jas were 
flowed into the chamber, and the chamber was returned to the previ-
ous xy-position on the stage to allow continuous imaging of the same 
cells. For imaging of ICAM-1 clusters, we used a planar bilayer con-
taining His-ICAM-1 labeled with X-rhodamine and monobiotinylated 
anti-CD3ε antibody labeled with Alexa 647. For measurements of the 
total intensity levels of Alexa 568–phalloidin and mGFP–F-tractin-P in 
the entire cell volume of Jurkat cells engaged on coverslip substrates, 
we imaged a 20-μm z-section of the cell using the NanoScanZ stage 
controller and measured the total integrated intensity through the 
entire z-stack per acquisition channel per cell using the region mea-
surement tool in MetaMorph software.
Analyses of actin flow and TCR MC movements
The dynamics of cortical F-actin and TCR MCs were measured after 
engaging Jurkat T cells with the planar bilayer by simultaneous im-
aging of mGFP–F-tractin-P and the anti-CD3ε antibody OKT3 la-
beled with X-rhodamine, using spinning disk confocal microscopy. 
For experiments with BB, we used monobiotinylated anti-CD3ε an-
tibody conjugated to Alexa 647 and Jurkat cells expressing tdTo-
mato–F-tractin-P to avoid imaging using blue light. For kymograph 
analyses of centripetal F-actin flow, the IS was separated into four 
quadrants, and a line was drawn from the distal edge to the cell 
center in each quadrant using MetaMorph software. Each kymo-
graph was made using a 2 × 2 line width (pixels). Four measure-
ments of F-actin flow rate, each generated by measuring the steep-
ness of the slopes using the kymograph analysis tool in MetaMorph, 
were made in the LP/dSMAC and LM/pSMAC regions within all four 
quadrants of the kymograph. The LP/dSMAC and LM/pSMAC re-
gions were demarcated by the abrupt change in the slope of F-actin 
flow that was invariably observed between these two regions. In 
low-dose CD- and Jas-treated cells, where the slopes of F-actin flow 
in the LP/dSMAC and LM/pSMAC regions were indistinguishable, 
the movement of F-actin before the addition of drugs was tracked in 
time-lapse images to define the LP/dSMAC and LM/pSMAC regions 
so as to mark their positions after drug addition. In BB-treated cells, 
where the kymograph of F-actin flow in the LM/pSMAC often con-
tained positive, negative, and vertical slopes (signifying inward, 
backward, and paused movements, respectively), only the positive 
slopes in the kymograph were included in the measurements. In all 
experiments, the rates of centripetal F-actin flow determined in all 
four quadrants of the cell were then averaged for the LP/dSMAC 
region and for the LM/pSMAC region to give a single value of cen-
tripetal F-actin flow rate for each region within a single cell. The 
means and standard deviations of F-actin flow rate per region were 
then calculated by averaging the single-cell values of all cells mea-
sured using Excel software (Microsoft, Redmond, WA). For analysis 
of TCR MC dynamics, the frame-to-frame movement of every visible 
TCR MC in each cell was tracked using the particle-tracking applica-
tion in MetaMorph software. The acquired images of TCR MCs and 
F-tractin-P were merged to allow identification of TCR MC move-
ments relative to the LP/dSMAC and LM/pSMAC regions of the IS. 
The instantaneous speeds of all TCR MCs were averaged per region 
to calculate the rate of TCR MC movement within the LP/dSMAC 
and LM/pSMAC regions in a single cell. Instantaneous values of 0 
were excluded from the calculation of TCR MC rates. The means 
and standard deviations of TCR MC movements per region were 
calculated by averaging the single-cell values of all cells measured 
using Excel software. The particle-tracking data were also used to 
calculate the meandering index (net displacement/total distance 
traveled) of TCR MC paths per region. The net displacement of each 
TCR MC path was calculated using the following formula:
Net displacement = square root[(X initial – X final)2 
+ (Y initial – Y final)2]
The total distance traveled was calculated by summing the dis-
tance between the frame-to-frame movements of all movements in 
each TCR MC path per IS region. Net displacement was divided by 
the total distance traveled to give the meandering index per TCR 
MC path, and the meandering index values of all TCR MC paths per 
region were averaged to give the meandering index values of TCR 
MC paths within the LP/dSMAC and LM/pSMAC regions in a single 
cell. The means and standard deviations of meandering index values 
per region were calculated by averaging the single-cell values of all 
cells measured using Excel software. For the analysis of TCR MC 
pausing data, the instantaneous speeds of all TCR MC movements in 
all cells were collected per region. We then binned the instantaneous 
speed values into two categories, 0 and >0, and counted the num-
ber of values in each bin. Each bin count was divided by the total 
number of instantaneous speed values to give the percentage of 
TCR MC movements at 0 or >0 per region. For the visualization TCR 
MC paths, we used the xy-position information from the particle-
tracking data to graph the TCR MC paths per region using SigmaPlot 
11.0 (Systat Software, San Jose, CA). For all statistical analyses, p 
values of >0.05 were considered to be not significantly different.
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